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ABSTRACT 
 
Indoleamine 2,3-dioxygenase (IDO) is responsible for the catalysis of tryptophan to 
tryptophan metabolites, which triggers a depletion of this essential amino acid and 
kynurenine accumulation in the microenvironment of T-cells. 
Tryptophan depletion through IDO was suggested as a molecular mechanism of IDO 
mediated immunosuppression and was also shown to activate the integrated stress 
response (ISR) via the GCN2 pathway in mice. This thesis aims to explore whether the 
effects of IDO on the GCN2 pathway are valid also in primary human T-cells, and whether 
the activation of the GCN2 pathway is associated with the impaired proliferative capacity in 
primary human T-cells upon sensing tryptophan deprivation.  
Our findings first confirmed that tryptophan deprivation accounts for the inhibition of 
proliferation in human T-lymphocytes. Although human primary T-cells are able to respond 
to an activation stimulus by highly expressed CD25 cell surface molecules, proliferation is 
inhibited. T-cell inhibition associated with tryptophan deprivation was accompanied by an 
increased susceptibility to apoptosis.  
Furthermore our data clearly indicated that, in contrast to the murine system, the integrated 
stress response was not induced upon tryptophan deprivation in primary human T-cells. 
Moreover, autophagy, an alternative stress related pathway, was not induced upon 
tryptophan withdrawal in the primary human system. Yet, the mammalian target of 
rapamycin (mTOR) pathway was inducible upon exposing primary human T-lymphocytes 
to enforced stress (tryptophan exhaustion, prolonged cell culture). 
In conclusion, in primary human T-cells, the initiation of the ISR and autophagy pathway 
apparently do not contribute to the cellular adaption to tryptophan deprivation. However, 
the mTOR pathway and increased apoptotic susceptibility may account for the T-cell 
inhibitory effects evoked by IDO activity.  
- 3 - 
KURZFASSUNG 
 
Indoleamine 2,3-dioxygenase (IDO) katalysiert die Umsetzung von Tryptophan zu 
Tryptophanmetaboliten. Dieser Prozess führt zur Erschöpfung dieser essentiellen 
Aminosäure in der direkten Umgebung der T-Zellen.  
In Mäusen wurde gezeigt, dass Tryptophanabbau durch IDO den „Integrated Stress 
Response“ auslöst und somit als molekularer Mechanismus für die IDO vermittelte 
Immunsuppression fungiert.  
Ziel dieser Arbeit war, die Effekte von IDO im besonderen Bezug auf den GCN2 Signalweg 
zu erforschen und infolgedessen auch den Einfluss von Tryptophanmangel resultierend 
aus der Aktivierung des GCN2 Signalweges auf die Proliferation von humanen T-Zellen zu 
ergründen.  
Unsere Resultate haben bestätigt, dass die Ursache für eine inhibierte T-Zellproliferation 
im humanen System durch Tryptophanmangel hervorgerufen wird. Obwohl primäre 
humane T-Zellen durch hohe CD25 Zelloberflächen Expression im Stande sind, auf 
Aktivierung zu reagieren, sind sie in ihrer Proliferation gehemmt. Neben dieser Inhibierung 
durch Tryptophanmangel wurde zusätzlich noch ein erhöhter Anteil an apoptotischen 
Zellen verzeichnet. 
Weiters verdeutlichten unsere Daten, dass der „Integrated Stress Response“, im Vergleich 
zum murinen System, in primären humanen T-Zellen nicht durch Tryptophanmangel 
hervorgerufen wird.  
Darüber hinaus wurde Autophagie, ein alternativer, durch Stress induzierter Signalweg, 
nicht durch Tryptophanentzug induziert.  
Dahingegen wurde der mTOR Signalweg durch erhöhten Stress, wie zum Beispiel 
Tryptophanmangel und längere Kultivierung im Medium, in primären humanen 
T-Lymphocyten aktiviert 
Zusammenfassend haben die Ergebnisse dieses Projektes gezeigt, dass der „Integrated 
Stress Response“ und Autophagie Signalweg in primären humanen T-Zellen offenbar 
keine Rolle in Bezug auf die zelluläre Antwort, bedingt durch Tryptophanmangel, spielt. 
Nichtsdestotrotz könnten der mTOR Signalweg und erhöhte Apoptose, hervorgerufen 
durch IDO spezifischen Tryptophanentzug, eine wichtige Bedeutung hinsichtlich der 
T-Zellinhibierung darstellen.     
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A - INTRODUCTION 
1 Immune System 
1.1 Innate Immunity 
The innate immune system is the most ancient defense mechanism of the human body, 
comprising germ-line encoded receptors for the recognition of microorganisms. [5]  
In the course of pathogen invasion through the skin, respiratory or gastrointestinal tract, 
pathogen associated molecular patterns of bacteria, viruses, protozoa and fungi, so called 
PAMPS (e.g. cell wall components of bacteria) are recognized by pattern recognition 
receptors (PRR) on immune cells. [6]  
This recognition is achieved by specialized PRRs, namely Toll-like receptors (TLRs), which 
were originally found and first described in Drosophila as the Toll gene. Later a homologue 
of it was discovered in the mammalian organism. [7] Toll-like receptors belong to type I 
transmembrane receptors comprising an extracellular leucine-rich motif, being responsible 
for the ligand binding, and an intracellular Toll/interleukin IL-1 receptor (TIR) domain, 
mediating the intracellular signaling. [8] So far 13 different mammalian TLRs are known, 
with TLR-4 being the first one discovered, playing a pivotal role in binding of the bacterial 
cell wall component lipopolysaccharide (LPS). [9] 
TLRs are expressed on immune cells like macrophages and dendritic cells (DCs), but can 
also be found on various tissues like endothelial, epithelial and muscle cells. [10] 
During an innate immune response, the first line defense comprises immune cells like 
macrophages, neutrophils and natural killer (NK) cells. Macrophages are able to 
phagocytose invading pathogens, thereby releasing inflammatory cytokines and 
chemokines, which lead to the permiabilization and enhanced expression of adhesion 
markers on vascular vessels for the recruitment of circulating leukocytes. [11] 
Neutrophils, which constitute around 70% of peripheral blood leukocytes, carry toxic 
metabolites, antimicrobial proteins and proteolytic enzymes, to override invading 
pathogens. [12]  
NK cells are participating in intrinsic killing via intracellular perforin and the extracellular 
surface molecule FasL. [13]    
 A – INTRODUCTION 
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If a PAMP binds to a Toll-like receptor, adaptor proteins are recruited to the cell membrane 
to associate with the intracellular domains of the TLR, finally leading to the activation of 
transcription factors (e.g. NFκB), which control and adapt gene expression (Fig. 1). [5] 
 
 
Fig. 1: Recognition of PAMPs through TLRs and their downstream signaling in mammalian cells [Dempsey et al., 2003][5]  
 
The upregulation of respective genes lead to various cellular responses like the production 
of cytokines and chemokines, which induces cell trafficking and DC maturation by 
upregulation of MHC complexes and costimulatory molecules, which finally lead to the 
activation of T-cells. [5] 
 
1.1.1 Dendritic Cells 
Dendritic cells, as afore mentioned, are mediators between the innate and the adaptive 
immunity. Dendritic cells migrate from the bone marrow via the blood stream to peripheral 
organs (Fig. 2). They are able to take up macromolecules and soluble antigens via different 
ways of engulfment, namely receptor mediated endocytosis, which includes the use of 
coated pits, and phagocytosis, which is accomplished by membrane ruffling through actin 
reorganization, which leads to the formation of large intracellular vacuoles. [14, 15]  
Maturation of dendritic cells can occur through various receptor signals: (i) Toll-like 
receptors on the cell surface, (ii) cytokine receptors, (iii) Fc receptors and (iv) cell death 
receptors. [14] 
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Toll-like receptor mediated maturation plays a pivotal role during infections, meaning that a 
dendritic cell is matured when it recognizes bacterial cell wall components through their 
TLRs. [16]  
Some critical molecules leading to the maturation of dendritic cells include TNF-α, IL1-β 
and PGE-2, which are especially excreted when the body encounters a bacterial infection. 
[17]  
Two factors, influencing dendritic cell maturation, are Fc receptors on dendritic cell 
surfaces, which can recognize immune complexes of antibodies and cell death receptors, 
leading to maturation through a danger signal of necrotic cells. [18-20]   
 
 
 
Fig. 2: Life cycle of a dendritic cell [Banchereau et al., 2000][17] 
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1.2 Adaptive Immunity 
Dendritic cells are kept in an immature state upon challenge with a pathogen, which leads 
to the maturation and concurrent expression of costimulatory molecules on the surface, 
inducing the migration to a draining lymph node. There, the dendritic cell primes the naïve 
T-cells through association via the immunological synapse (Fig. 3), comprising two main 
ligands: (i) T-cell receptor - MHC interaction concurrently with CD4/CD8 molecules, (ii) and 
costimulatory molecules CD28-CD80/CD86 interaction. Finally, this leads to the expansion 
and proliferation of T-cells, which accounts for the adaptive immune response. [5] 
 
 
Fig. 3: Formation of the immunological synapse between an APC and a T-lymphocyte depicting the main interacting ligands  
[Huppa and Davis, 2003][21]  
 
 
1.2.1 T-cells 
Priming of T-cells in the lymphnode through a dendritic cell, which presents the appropriate 
antigen in the compatible MHC complex, is achieved through three distinct signals (Fig. 
4). [22] 
 A – INTRODUCTION 
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Fig. 4: Three distinct signals in T-cell priming [Gutcher and Becher, 2007][22] 
 
Signal 1 represents the binding of the T-cell receptor to the matched MHC complex with 
the presented antigen epitope on the antigen presenting cell (APC). However, this signal 
does not fulfill the requirements for the activation of a T-cell, since two other crucial signals 
are needed for full activation. 
Signal 2 is characterized by the association of several costimulation molecules, amongst 
others CD80 (B7.1) and CD86 (B7.2) on the dendritic cell and CD28 on the T-cell. This 
joining, which is called costimulation, markedly affects clonal T-cell proliferation. Another 
costimulation molecule affecting the priming of T-cells is CTLA-4 (CD152), which as well 
joins up with CD80/86 on dendritic cells, but acts as inhibitory signal to the T-lymphocytes.  
Signal 3, required for full T-cell priming, is the cytokine excretion. It has been shown that 
IL-12 and IL-18 are key players during the differentiation of T-cells into a Th1 phenotype, 
whereas expression of IL-4 by T-cells favors the differentiation into a Th2 phenotype (Fig. 
5).[23, 24]   
 
 
Fig. 5: T-cell polarization through various effector cytokines [Gutcher and Becher, 2007][22]    
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1.2.1.1 CD4 T-cells 
In 1986, two distinct subsets of CD4 T-cells have been originally described by Mosmann 
and Coffman. [25] Generally, CD4 T-cells play a pivotal role during infections in shaping 
immune reactions. These cells exert the ability of activating macrophages, aid B-cells for 
producing antibodies and recruit eosinophiles, neutrophiles and basophiles to the site of 
infection.  
Up to now at least 4 different T-cell subsets are known, each possessing different effector 
functions (Fig. 6). [25, 26]  
 
 
Fig. 6: CD4 T-cell subsets with expressed cytokine profiles and their immunologic effects [Zhu and Paul, 2008][26]  
 
Th1 subset 
The Th1 T-cell subset plays a critical role during the immune reaction against intracellular 
pathogens like mycobacteria, but has also been shown to induce various kinds of 
autoimmune diseases. [27, 28] Their typical cytokine profile comprises IFN-γ, lymphotoxin α 
(LTα) and IL-2, which leads to the activation of macrophages and T-cell memory. [29, 30]  
 
Th2 subset 
Th2 T-cells are vitally important for the immunological defense against extracellular 
pathogens, but have also been suggested to contribute to asthmatic reactions and allergic 
diseases. [27, 28] Cytokines produced by Th2 cells include IL-4, IL-5, IL-9, IL-10, IL-13, IL-25 
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and amphiregulin, which possess a major role in class switching of B-cells and Th2 
differentiation. [31-33]  
 
Th17 subset 
The Th17 T-cell subset was shown to be involved in the body’s defense against 
extracellular bacteria and fungi, but also in the development of organ specific autoimmune 
diseases. [34] Cytokines expressed by Th17 cells include IL-17a, IL-17f, IL-21 and IL-22, 
which have been shown to be involved in the induction of inflammatory processes, 
activating neutrophils, CD8 T-cells, B-cells, natural killer cells and dendritic cells. [35, 36]   
 
Treg subset 
Regulatory T-cells, as afore mentioned, play a pivotal role during the induction of 
self-tolerance and prevention of graft rejection via mediating immunosuppressive effects 
and are defined by the expression of the cell surface markers CD4 and CD25 and the 
intracellular transcription factor Foxp3. [37] Tregs are able to express TGF-β, IL-10 and IL-35, 
which act on the differentiation of CD4 T-cells into iTregs, and suppression of inflammatory 
diseases. [26] 
 
1.2.1.2 CD8+ T-cells 
Cytotoxic CD8+ T-cells are central mediators in the defense of intracellular pathogens. 
CD8+ T-lymphocytes are able to recognize antigens, which are presented in an MHC-I 
dependent context. Cytotoxic T-lymphocytes are able to directly kill target cells by cytolysis 
through perforin and the cell surface receptor Fas, but were also shown to express a range 
of inflammatory cytokines such as TNF and IFN-γ. Additionally, CD8+ T-cells are as well 
able to secrete chemokines, which act as an attractant for inflammatory cells. [38, 39]  
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2 Hematopoietic Stem Cell Transplantation 
Over fifty years ago, in the year 1959, the first successful hematopoietic stem cell 
transplantation (HSCT) was performed (Fig. 7). [40] To date more than 25 000 HSCTs per 
year are conducted all over the world to treat diseases like lymphomas, leukemias, 
immune-deficiency illnesses, congenital metabolic defects, hemoglobinopathies and 
myelodysplastic and myeloproliferative syndroms. [41]  
Originally, HSCT was applied for two main reasons: to treat patients with inherited 
anaemias or immune deficiencies with high myeloablative chemotherapeutic or radiation 
doses [40] 
  
 
Fig. 7: Timeline of hematopoietic stem cell transplantation innovations over more than 50 years [Jenq and van den Brink, 2010] [40] 
 
In the beginning of exploring the features of HSCT, infused bone marrow was found to 
rescue rodents after receiving lethal doses of radiation. [42]  
 
2.1 Hematopoietic Stem Cells 
Hematopoietic stem cells (HSC) are capable of the ability of indefinite self renewal and 
differentiation into all mature blood lineages. [43, 44]  
So far, hematopoietic stem cells are defined by the cell surface marker CD34 and can be 
derived from peripheral blood, bone marrow or umbilical cord blood. [45] The selection of the 
stem cell source for HSCT, which can derive from autologous, syngeneic or allogeneic 
donors, is influenced by various factors like donor availability or transplantation indication. 
[41] The stem cell graft can be derived from different types of donors. HSC donors can be 
grouped into 3 classes: (i) matched related donors, represented by siblings, (ii) matched 
 A – INTRODUCTION 
- 17 - 
unrelated donors, constituted by MHC matched foreign donors and (iii) haploidentical 
donors, represented by parents. [46]  
2.1.1 Bone Marrow derived Stem Cells 
Bone marrow is usually harvested from the posterior iliac crest, filtered and afterwards 
either directly infused into the recipient or stored at 4°C up to 24h without cell loss, which 
makes the intercontinental transfer easy and applicable. Usually a cell dose of 
2*108 cells/kg body weight is infused in the patient, meaning at least 700-1500 ml bone 
marrow have to be harvested. [41] 
2.1.2 Peripheral Blood Stem Cells 
The second source of hematopoietic stem cells is peripheral blood. The method of 
harvesting peripheral blood stem cells is much easier, less inconvenient and leads to a 
faster recovery of neurophils and platelets after transfusion (Fig. 8). [47, 48] Since peripheral 
blood stems cells are naturally present in low numbers in the peripheral blood, donors are 
pretreated with granulocyte-colony stimulating factor (G-CSF), which triggers the 
proliferation and accumulation of the stem cells in the peripheral blood. [41] 
Unfortunately the administration of G-CSF can elicit some adverse side effects like bone 
pain, headache, fatigue and nausea. [49] Another severe disadvantage of using peripheral 
blood stem cells is that patients may evolve a slightly higher risk of developing a 
graft-versus-host disease (GvHD; see section 2.3).[50, 51] 
 
Fig. 8: Peripheral blood hematopoietic stem cell transplantation procedure [Shlomchik, 2007] [52] 
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2.1.3 Umbilical Cord Blood Stem Cells 
The transplantation of stem cells from umbilical cord blood is a safe and easy available 
procedure, which alleviates the risk of carryover viruses and developing severe side effect 
like GvHD due to the higher content of immature and naïve cells. [53] A match of 3-4 of the 
6 HLA-A, HLA-B and HLA-DRB1 available antigens is acceptable with this kind of 
transplantation method. Due to the fact, that a lower quantity of cells is present in umbilical 
cord blood, the patient’s immune system needs more time for recovery and regeneration, 
which in turn increases the risk of acquiring infections. [54] 
 
2.2 Transplantation process 
The transplantation process of a HSCT actually starts one week before (day -7 to day 0) 
transfusion of the stem cells. In this week, the patient is undergoing a conditioning regimen, 
meaning he is receiving high dose chemotherapy (cyclophosphamide is widely used) and 
often additionally radiotherapy (total body irradiation) to make sure that the preceding 
malignant disease is completely eradicated. [55] These harsh regimen doses destroy the 
recipient’s immune system, which elicits on the one hand negative effects since the 
patient’s body is not able to react to infections, but on the other hand evokes positive 
effects due to the fact, that cancer cells are eradicated and the patient’s immune system as 
well can’t initiate an immunological reaction against the infused donor stem cells. 
Unfortunately patients can develop side effects upon the administered conditioning 
regimen like oropharyngeal mucositis (Fig. 9) [56]   
 
 
 
 
 
 
Fig. 9: Indications for oropharyngeal mucositis after conditioning regimen [Léger and Nevill, 2004] [56] 
 
On day 0 of HSCT the donor stem cells are transfused into the patient. From this timepoint 
on, the patient is susceptible to bacterial, viral and fungal infections, especially due to 
 A – INTRODUCTION 
- 19 - 
breaks in the natural mucosa and skin barriers, since the patient’s immune system was 
destroyed and the new donor immune system isn’t fully reconstituted yet (Fig. 10). This 
susceptibility to infections and the risk of developing a Graft-versus-Host Disease ranges 
from day 0 of transplantation up to day 180 post-transplantation. [56] 
 
Immune ablation Immune reconstitution
DYSREGULATION
-10                                            0              30 100                                           180 days of HSCT
H
S
C
T
GvHD
bacterial infections
viral/fungal infections
myeloid
lymphoid
IMMUNE
COMPETENCE
Cellular recovery
TOLERANCE
 
Fig. 10: Immune reconstitution after HSCT 
[kindly provided by Birgit Jürgens, PhD] 
 
2.3 Graft-versus-Host Disease 
Billingham defined the requirements for developing GvHD in the year 1966 by following 
statements: (i) there have to be a sufficient number of immunologically competent cells in 
the graft; (ii) the host has to hold major antigens, which are missing at the graft’s side; 
(iii) the host’s immune repertoire has to be in a aggrieved condition, so that it is not able to 
initiate a immune response against graft cells. [57]  
GvHD can be divided into two subgroups: (i) acute GvHD (aGvHD), which emerges within 
100 days post-transplantation, and (ii) chronic GvHD (cGvHD) after 100 days 
post-transplantation. [56] The severity of GvHD can also be classified into different grades, 
namely clinically insignificant with the grades 0 and I and clinically significant with the 
grades II to IV. [41]  
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Despite better HLA-typing procedures and immune suppression, Graft-versus-Host 
Disease (GvHD), which is frequently linked with high morbidity and mortality, remains a 
major problem after HSCTs. The risk of developing an acute GvHD after HSCT is about 
40%, but can range from 10-80%, depending on various risk factors (see sections 2.3.1-0). 
[41]  
 
2.3.1 Genetic impact factors for the development of GvHD 
The most prominent factor influencing the development of GvHD is the Human Leukocyte 
Antigen (HLA), which is located on the short arm of chromosome 6 and presented by the 
Major Histocompatibility Complex (MHC), which plays a pivotal role in the humoral and 
cell-mediated immune response (Fig. 11).  
 
 
Fig. 11: Chromosome 6 with encoded HLA I and II complexes [Winslow, 2012][58] 
 
The class I cell surface molecules (HLA-A, B- and C) are expressed on all nucleated cells 
in the human body, whereas the majority of class II molecules (DR, DQ and DP) are 
expressed on cells of the immune system and in particular found in the skin and the GI 
tract in high numbers. [59] 
Another factor which influences the prediction of GvHD after HSCT is the Minor 
Histocompatibility Antigen (miHA). miHA are small peptides processed from intracellular 
proteins, which can vary due to genetic polymorphisms (Fig. 12). This variation affects the 
outcome of HSCT even between MHC matched siblings. [60, 61]  
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Fig. 12: Recognition of the miHA by recipient and donor APCs [Shlomchik, 2007] [52] 
 
2.3.2 Non-HLA dependent factors for GvHD 
Cytokine gene polymorphism was suggested to be one non-genetic mechanism 
contributing to the development of GvHD. So far, various kinds of cytokines are suggested 
to enhance the symptoms of GvHD. Inter alia, gene polymorphisms in TNF-α, IL-10, IL-6, 
IFN-γ, IL-1, TGF-β, IL-2, IL-13 and IL-4 are linked to an increased susceptibility for 
developing GvHD. [62]  
Another non-HLA dependent factor affecting the progression of GvHD is the 
NOD2/CARD15 gene, which plays a central role in the innate immune response when 
responding to bacterial infections in the GI tract via the initiation of nuclear factor-κB 
(NF-κB). If this gene experiences a single nucleotide polymorphism (three are known up to 
now), NF-κB levels are alleviated, and the risk for developing Crohn’s disease and GvHD 
rises. [59, 63]  
Other non-genetic risk factors for developing an acute GvHD are donor and recipient 
gender differences, alloimmunized donors (women, who gave birth to at least three 
children), increased age of the host, donor graft type, donor and host cytomegalovirus 
(CMV) status and preceding conditioning regimen. [41, 64, 65]   
 
2.3.3 Course of acute GvHD 
aGvHD can be divided into three phases: (i) the afferent phase, (ii) the induction and 
expansion phase (iii) and the effector phase (Fig. 13). [66] Due to preceding conditioning 
regimens, damages and thus activation of the intestinal flora take place, which enables 
bacterial lipopolysaccharides to transverse the intestinal lumen and manage to enter the 
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circulation system during the afferent phase. These bacterial cell wall products thereby 
trigger the release of inflammatory cytokines (the so-called “cytokine-storm” like IL-1, 
TNF-α, IL-6 and IFN-γ) which lead to the activation of innate immune cells via Toll-like or 
NOD-like receptors. [40] These activated innate immune cells then in turn again secrete 
inflammatory cytokines which initiate the enhanced expression of MHC, co-stimulatory and 
adhesion molecules. [40, 67-69]  This upregulation of APC cell surface molecules induces the 
second phase of GvHD. Donor T-cells receive a proliferation and expansion stimulus via 
contact-dependent activation by APCs and indirectly via the effects of cytokines. Donor 
T-lymphocytes react by producing IL-2 and IFN-γ, which in turn activate other T-cells and 
natural killer cells and induce macrophages to produce TNF-α thereby injuring the GI tract 
and skin mucosal surfaces. [25, 70, 71]  
In the third and last phase, cytotoxic T-lymphocytes initiate damage through Fas-Fas ligand 
interaction, perforin-granzyme combination and TNF-α expression. TNF-α in turn triggers 
the release of IL-1, IL-6, IL-10, IL-12 and again TNF-α. [72-74]  
The use of T-cell depleted HSC transfusions was shown to reduce the risk of developing 
GvHD and abrogates the use of immunosuppressive agents, but increases the risk of a 
malignant relapse. [75, 76]    
 
 
Fig. 13: Course of acute GvHD with interacting immune cells and affected body damage sites [Jenq and van den Brink, 2010] [40] 
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2.3.4 Symptoms of acute GvHD 
Acute GvHD primarily affects the skin, upper and lower GI tract and the liver, but can 
sometimes also manifest as eye and oral mucosal damage. The classical symptom of 
acute skin GvHD is a skin rash, which covers hand palms, foot soles and later distributes 
over the face, neck, upper chest and trunk. In very severe forms the progress could lead to 
erythroderma including bullae formation and desquamation (Fig. 14).  
 
 
Fig. 14: Erythroderma formation in stage IV aGvHD [Ball and Egeler, 2008][59] 
 
During an acute liver GvHD, increased levels of alkaline phosphatase and an isolated 
billirubinemia could be observed.  
In an acute GI GvHD, diarrhea, anorexia and nausea emerge. In later stages abdominal 
pain, GI bleeding and ileus arise as prevalent syndroms. [59]   
 
2.4 Cells involved in GvHD 
2.4.1 APCs 
Antigen presenting cells (APCs) constitute a major cell population in the context of 
developing aGvHD. Professional APCs, especially dendritic cells (DCs), possess the ability 
of digesting proteins and loading peptide antigens on MHC complexes, transferring them to 
the cell surface and presenting them in combination with costimulatory and leukocyte 
antigen molecules via formation of the immunological synapse to T-cells. [17]  Two possible 
pathways for loading dendritic cells exist: the endogenous and the exogenous pathway. In 
the endogenous loading pathway, intracellular proteins are degraded, passed on to the 
endoplasmic reticulum where they are loaded on MHC I molecules. During the exogenous 
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loading pathway, antigens are phagocytosed, hydrolyzed by peptidases and then loaded 
onto MHC II molecules. [77] APCs possess the ability of presenting extracellular antigens in 
an MHC I context. This process is called crosspresentation and vitally important for the 
development of immunity to infectious agents or tumors. [78]  
In other words, in an MHC matched setting, proteins from the cytosol are degraded by a 
recipient APC, loaded onto a MHC I system and finally recognized by a donor CD8+ T-cells 
as foreign antigen. When an antigen is exogenenously uptaken via endocytosis by a 
recipient or donor APC, it is processed and presented in the context of MHC class II, which 
is able to activate CD4+ donor T-lymphocytes (Fig. 15).  
Concerning the situation after a HSCT this means that directly after transplantation host 
alloantigens are directly presented by host APCs or presented by donor APCs to donor 
T-cells.  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Fig. 15: MHC class I and II presentation by recipient APCs to donor CD8+ and CD4+ T-lymphocytes [Shlomchik, 2007][52] 
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2.4.2 T-cell populations 
Overall, particularly CD8+ T-cells, upon interplay with APCs, is the central effector cell 
population in GvHD. [79, 80] CD4+ T-cells were also shown to play an essential role in the 
expansion of CD8+ T-lymphocytes, but recently were also suggested to initiate GvHD after 
depletion of CD8+ T-cells. [81]  
Regulatory T-cells (Tregs) were shown to play a vital role in the development of GvHD. 
Regulatory cells were shown to prevent GvHD when infused into mice. [82] In line with these 
observations is, that if CD25+ T-cells are depleted from the graft, development of acute and 
chronic GvHD is enhanced. [83]  
Another inhibitory cell population is the Natural Killer T-cell (NKT), which expresses NK- 
and T-cell surface markers. Increased numbers of these cells can be found in peripheral 
blood stem cell apheresis products, when donors were pretreated with G-CSF, and show a 
decreased potential to develop GvHD when infused. [84, 85]  
 
2.4.3 NK-cell population 
Natural killer (NK) cells play a pivotal role during immune responses. This cell population is 
able to distinguish healthy, leaving them unaffected, versus diseased and allogeneic cells, 
initiating lysis for removing them from the system. NK cells possess the ability to express 
cell surface receptors, so called killer-immunoglobulin receptors (KIRs), which predicts the 
alloreactivity e.g. after a stem cell transplantation. Published data state that GvHD inter alia 
evolves, if the recipient is lacking killer-immunoglobulin receptor ligands, leading to the 
lysis of allogeneic donor cells. [86] 
2.4.4 B-cell population 
The specific role of B-cells, central players in the immune system and as well involved in 
the development of aGvHD, is still not completely unraveled. On the one hand, 
B-lymphocytes are able to induce antibody-dependent complement activation and 
cell-mediated cytotoxicity. Moreover, B-cells secrete proinflammatory cytokines like IL-2, 
TNF-α, IL-6, IL-12 and IFN-γ, which trigger the activation of T-cells, NK-cells and 
macrophages. A decreased incidence of developing GvHD was shown upon B-cell 
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depletion in mice. [87] These observations are consistent with published results in humans 
which show that high numbers of B-lymphocytes in the donor apheresis graft result in an 
increased incidence of developing aGvHD. [88] However, on the other hand B-cells are also 
able to exert immunoregulatory effects, for example by IL-10 production. [89]    
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3 Tolerance 
Tolerance, which is defined as the unresponsiveness to (self-) antigens, can be classified 
into two categories: (i) the central tolerance induction and (ii) the peripheral tolerance 
induction. [90, 91] 
 
3.1 Central Tolerance 
Central tolerance takes place in the central primary lymphoid organ, the thymus. The 
thymus consists of three distinct areas: (i) the outer subcapsular zone, (ii) the cortex and 
(iii) the inner medulla. Generally spoken, the thymus represents the location, where naïve 
T-cells are matured by confronting them with self-antigens. [92] 
In the subcapsular zone mostly completely immature T-lymphocytes, which recently 
migrated from the bone marrow to the thymus, can be found, expressing neither a CD4 nor 
CD8 cell surface marker. After the cells arrived in the subcapsular region, they migrate 
deeper into the thymus to enter the cortex area, where the actual selection and maturation 
procedure starts. CD4- CD8- T-lymphocytes start to rearrange their T-cell receptor (TCR) 
chains (α+β) and begin to express both CD4 and CD8 cell surface markers. During this 
stage of maturation, specific epithelial cells start to express MHC class I and II molecules 
and present self-antigens in this context. If the semi-mature T-lymphocytes show a strong 
avidity to self-peptide, which means that they are potentially autoreactive, or are not even 
able to recognize self antigen at all, they are deleted by apoptotic mechanisms (Fig. 16). [93] 
However, if the semi-mature T-lymphocytes recognize the self-antigens with low, but 
measurable affinity, they are positively selected and differentiated (after travelling to the 
central region of the thymus) either into CD4+ CD8-, later on able to recognize antigens 
presented in an MHC class II context, or CD4- CD8+ mature T-cells with the ability to 
recognize MHC class I molecules. After this positive selection, the mature T-cells travel to 
their operational area, the secondary lymphoid organs. [92, 94, 95]  
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Fig. 16: Deletion of self reactive T-cells in the Thymus [Janeway’s Immunobiology, 2008][96]  
 
3.2 Peripheral Tolerance 
Due to the fact that not all self-antigens can be produced by these specialized epithelial 
cells in the thymus, some T-cells escape this clonal selection process and would be able to 
induce an autoimmune reaction in the periphery. So far, there are three ways known, to 
inhibit any potential autoimmune reactivity of T-cells (Fig. 17). [96] 
 
 
Fig. 17: Three ways of inhibiting the autoreactive action of T-lymphocytes [Abbas et al., 2004][90] 
 
One mechanism is that the autoreactive T-cell is silenced through a process called anergy. 
In this case, the T-cell forms an immunological synapse with an APC which lacks the 
additional costimulatory molecules on its surface. (Fig. 18) This leads to the shutdown of 
the cell rendering it unable, to react to any environmental signals, meaning to enter a stage 
of functional unresponsiveness. Anergy may also be induced upon expression of inhibitory 
molecules on the surface of T-cells. This inhibitory receptor (CTLA-4) interacts with the 
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CD80/86 molecule complex on the APC and drives the T-lymphocyte into an anergic state, 
unable to respond. [90]  
 
Fig. 18: Induction of anergy due to missing  costimulatory molecules [Janeway’s Immunobiology, 2008][96] 
 
The second prominent way of inhibiting autoreactive T-cells is to induce apoptosis. If a 
T-lymphocyte was recently activated by an antigen and is shortly thereon restimulated by 
the same antigen, the T-cell starts to coexpress death receptors on its surface, namely Fas 
receptor (FasR or CD95) and Fas-ligand (FasL or CD95L). The interaction with these 
receptors leads to an intracellular activation of caspase cascades ultimately driving the cell 
into apoptosis. [90]  
The last alternative of inhibiting autoreactive T-cells is via the action of regulatory T-cells 
(Tregs). During the clonal selection process in the thymus, Tregs recognize self-antigen with 
low affinity, therefore neither be negatively deleted by too strong recognition nor simply 
positively selected. These regulatory T-cells then migrate to the periphery, where they 
encounter their self-antigens presented by an APC, inducing the secretion of 
anti-inflammatory cytokines as IL-10 and TGF-β, thus acting in an inhibitory fashion on 
self-reactive T-cells (Fig. 19). [90, 97]  
 
Fig. 19: Clonal selection of Tregs in the thymus and action of even those on self-reactive T-cells in the periphery [Janeway’s 
Immunobiology, 2008][96] 
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4 Indoleamie 2,3-dioxygenase 
Indoleamine 2,3-dioxygenase (IDO) is an intracellular enzyme (no secreted or extracellular 
form is known until now) which was first identified in rabbit intestines and attributed to 
contribute to the antimicrobial defense in the body. [98-100] The protein is encoded by one 
gene located on chromosome 8 with a size of around 15 kbp which comprises 10 exons. 
The gene is highly conserved amongst various species but was evolutionary adapted for 
different applications. [101] The promoter region of IDO comprises various sequence 
elements, inter alia sequences for responding to type I (α- and β) and more effectively type 
II interferons (γ). [102-105] Upon preceding activation of the IDO gene promoter through e.g. 
IFN-γ via the JAK/STAT signaling pathway, which act on interferon stimulatory response 
elements (ISREs) and γ-activating sequences (GAS), the IDO gene is 
transcribed/translated, resulting in an inactive around 45 kDa big apoenzyme. 
Subsequently, the incorporation of the haeme prosthetic group takes place, which converts 
the apoenzyme in an inactive IDO holoenzyme. To end up in a fully functional IDO enzyme, 
potential posttranslational modifications (PTMs) are initiated. Although some of the most 
important IDO PTMs, like oxidation, nitration, N-terminal acetylation and phosphorylation 
are known, most of IDO’s PMTs remain unclear so far. (Fig. 20) [106]     
 
        
Fig. 20: Molecular Genetics of the IDO gene and protein [Mellor and Munn, 2004] [2] and post translational modifications  
 [Fujigaki, 2012] [106]   
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IFN-γ was shown to be essential for IDO induction in vitro, and potentiated in the interplay 
with lipopolysaccharide (LPS), interleukin-1 (IL-1) and tumor necrosis factor (TNF). [107-109]  
This enzyme holds the ability to initiate the breakdown of the essential amino acid 
tryptophan to tryptophan metabolites. [110] IDO is primarily present in immune cells, e.g. 
antigen presenting cells (APCs) and in a vast amount of various other tissues comprising 
endothelial cells[111], astrocytes[112], eosinophilic granulocytes[113], bone marrow stromal 
cells[114] and tumor cells[115].  
An innovative finding around the group Munn et al. revolutionized the whole thinking about 
IDO and its characteristics. As aforementioned, IDO was thought to contribute to the 
antimicrobial defense mechanism by depleting tryptophan in the inflammatory 
microenvironment, Munn et al. showed that tryptophan depletion plays a pivotal role in 
preventing T-cell driven fetal rejection, especially during pregnancy in mammals. [116] 
Moreover IDO is suspected to contribute to the immunological escape of tumors via 
depletion of tryptophan (Fig. 21). [117]  
 
 
Fig. 21: Function of IDO [Terness et al.,2002][1] 
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4.1 Theories about IDO 
Up to now two main theories about the function of IDO exist.  
 
4.1.1 Tryptophan Starvation Theory 
The first theory deals with tryptophan starvation, where IDO is supposed to act in a similar 
fashion on T-cells as on bacteria, viruses and parasites. [1, 118] This theory signifies that 
through the action of IDO local tryptophan storages are used up, which makes 
T-lymphocytes more prone to apoptosis. If T-cells are depleted from the essential amino 
acid tryptophan, they use to initiate cell cycle arrest and anergy in the first phase of amino 
acid starvation. [4, 118, 119] Nevertheless this state can easily be reversed by supplying cells 
with excess tryptophan thus reversing the IDO induced anergy. [118, 120-123] 
The group around Munn et al. claimed that the local tryptophan concentration in 
surrounding T-cells has range between 0,5 µM and 1 µM to inhibit T-cell proliferation. [118] 
Interestingly, Frumento and colleagues affirmed that even in medium completely deplete of 
tryptophan, they could not observe a decreased T-cell proliferation. [124]  
However, this theory should be regarded with suspicion, since local tryptophan 
concentrations in vivo range from 50 µM to 100 µM and can easily be restored by diffusion 
from the surrounding environment. [125]  
 
4.1.2 Tryptophan Metabolite Theory 
The second theory around IDO is the so called “tryptophan metabolite theory”. This theory 
states that upon tryptophan consumption tryptophan metabolites, so called kynurenines 
(especially 3-hydroxykynurenine and 3-hydroxyanthranilic acid), accumulate and force 
T-cells into cell cycle arrest or an apoptotic course due to their toxic effects. [124, 126, 127]  
Furthermore kynurenines are also thought to induce differentiation of CD4+ T-cells into an 
immunosuppressive regulatory phenotype. [128] Up to now it seems that both mechanisms 
are contributing to the effects of IDO.  
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4.2 Tryptophan Degradation Pathway 
In the course of tryptophan degradation, dietary tryptophan (around 99%), which is not 
used for protein synthesis, is metabolized along the tryptophan degradation pathway (Fig. 
22). The residual 1% are converted into serotonin in the nervous system or gut or 
metabolized to melatonin in the pineal gland. [129] In the rate limiting step the 2,3 double 
bond of the indole ring of tryptophan is converted to kynurenine by oxidative cleavage 
mediated through either tryptophan 2,3 dioxygenase (TDO) or indoleamine 2,3 dioxigenase 
(IDO). [2] TDO is exclusively present in the liver where it catalyzes the conversion of 
tryptophan under steady-state conditions. [130, 131] Under inflammatory conditions enhanced 
IDO activity can be observed for the purpose of decreasing the local tryptophan 
environment.    
 
Fig. 22: Tryptophan degradation pathway [Iweala and Nagler, 2006][129] 
 
4.3 IDO and Tolerance 
IDO is assumed to play central role in immunological tolerance. During the late course of 
inflammation, antigen specific T-cells were described to release the potent immunological 
effector molecule interferon γ (IFN-γ), which acts in a paracrine dependent manner on 
denditic cells (DCs). This action implicates that DCs initiate the activation induced cell 
death to control T-cell homeostasis. [132] 
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As afore mentioned, Munn et al. discovered in 1998, that IDO contributes to the inhibition 
of fetal rejection at the maternal-fetal interface during pregnancy in mice. The group claims 
that IDO expression is restricted to primary trophoblast giant cells (TGCs) of fetal origin 
(entirely maternally inherited) in the perinuclear region. Interestingly, after placentation no 
IDO expression could be observed. Astonishingly, IDO deficient mice were able to produce 
normal healthy offspring, which points out that there has to be a compensatory or 
redundant immunosuppressive effect at the maternal-fetal interface preventing the rejection 
of the fetus. [133] 
Moreover, IDO was shown to be constitutively expressed by extravillous trophoblast cells 
at the maternal-fetal interface in the human system. [134-137] 
Another tolerance phenomenon can be observed in the case of autoimmunity. Primarily it 
was assumed that potential autoreactive T-cells are sent into apoptosis by dendritic cells 
activated through IFN-γ for maintaining peripheral tolerance and preventing autoimmunity. 
[1] Now it is known that IDO doesn’t solely regulate the constitutive maintenance of 
selftolerance, since IDO depleted mice don’t develop any lethal autoimmune diseases. 
Therefore IDO is rather categorized to be involved in acquired peripheral tolerance. [138]   
Acquired tolerance could be harmful in the context of cancer development (Fig. 23), but 
can also have a beneficial impact regarding the tolerance induction against foreign 
antigens from the fetus or antigens at mucosal surfaces. [139]  
 
 
Fig. 23: Negative effects of IDO expression for the immunological reaction against tumor cells [Munn and Mellor, 2007][138]  
 
In the context of defective self tolerance in the case of autoimmune diseases, IDO had 
been shown to worsen the effects and symptoms when inhibited in an EAE mouse model 
system. [140] On the other hand, if IDO is overexpressed it seems that immune responses 
are suppressed to a certain extent. This was astonishingly shown via the engraftment of 
IDO transfected MHC-mismatched murine lungs, preventing rejection without any 
immunosuppression. [141, 142] 
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More and more evidences accumulate that the downstream signaling of IDO, which result 
in tryptophan metabolites, accounts for the tolerogenic effect of T-lymphocytes, meaning 
inhibition of T-cell proliferation, and impairing NK-cell function. [124, 126, 143-145] 
The working mechanism of kynurenines is not clear until now, however the G-protein 
coupled receptor GPR35 was supposed to bind the tryptophan metabolite kynurenic acid. 
However, the exact biological function of this orphan receptor is still unclear, since the 
correlation came about the finding that this receptor is highly expressed at specific sites in 
the gut where IDO is known to be as well highly expressed. [146] The induced expression of 
IDO in destined cells makes clear, that IDO, since it would be toxic if constitutively 
expressed through consummation of tryptophan, has to be tightly regulated in each 
system. [2]  
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5 Translation Process 
5.1 Ribosome Structure 
The structure of the eukaryotic ribosomal complex was resolved by cryo-electron 
microscopy (Fig. 24) [147]. These data showed a high structural homology between the 
pro- and eukaryotic ribosomal complex, allowing to model the interactions in the eukaryotic 
complex with the help of high resolution prokaryotic crystal structures and eukaryotic 
biochemical data. [148]   
 
Fig. 24: (a) Cryoelectron microscopy analysis of the 40S subunit and (b) modeling of initiation factor recruitment [Jackson et al., 2010] [148] 
 
The ribosomal complex comprises three binding sites for tRNA (transfer RNA): 
(i) aminoacyl (A) site which has a high binding affinity for amino-acyl tRNAs (aa-tRNA), (ii) 
peptidyl (P) site which has a high binding affinity for peptidyl tRNAs and (iii) the exit (E) 
site, which has a high binding affinity for deacetylated tRNAs [149].  
 
5.2 Translational Mechanism 
The process of protein synthesis comprises three phases: (i) initiation, (ii) elongation and 
(iii) termination (with subsequent recycling). [150, 151] 
 
5.2.1 Translation Initiation 
Simplistically spoken, the phase of translation initiation comprises the steps of (i) codon-
anticodon basepairing, (ii) selection of the initiator tRNA, (iii) scanning for the appropriate 
starting site and (iv) joining of the ribosomal subunits (Fig. 25).  
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In other words the eukaryotic initiation factor 2 (eIF2), which is GTP bound, and the initiator 
tRNA (Met-tRNA) assemble and build a complex, also known as the ternary complex (see 
Fig. 25/2). GTP is higher in its energetic status, since three phosphate residues are bound, 
than GDP, which is why GTP is bound to eIF2 to initiate translation. Subsequently after 
ternary complex formation, the 40S ribosomal subunit and various initiation factors (eIF1, 
eIF1A, eIF3, eIF5 and eIF2-GTP-Met-tRNA) assemble, building together the so called 43S 
preinitiation complex (see Fig. 25/3). [148, 152] 
After assembly, the eukaryotic initiation factor 4E binds the 7-methylguanosine at the 
5’ cap of the mRNA and concurrently eIF4F and eIF4B are starting to unwind the mRNA at 
the cap-proximal region, thereby activating it (see Fig. 25/4). [153] 
Thereafter the 43S preinitiation complex binds to the mRNA and scans for the appropriate 
start codon (see Fig. 25/5+6). Right after this process, the 48S initiation complex formation 
takes place (see Fig. 25/7) which switches the entire system to a closed conformation, 
leading to a displacement of the factor eIF1 to allow GTP hydrolysis by eIF5 (GDP-bound 
eIF2 was shown to have a 10-fold lower affinity to bind Met-t-RNAiMet [154]). Mediated by 
eIF5B, eIF2-GDP and various other factors (eIF1, eIF3, eIF4B, eIF4F and eIF5) dissociate 
after attachment of the 60S ribosomal subunit to the complex (Fig. 25/8). Finally GTP is 
hydrolysed to GDP, which is mediated by eIF5B, and the factor eIF1A is released (Fig. 
25/9). [148] 
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Fig. 25: Process of Eukaryotic Translation Initiation with subsequent recycling of the ribosomal subunits [Jackson et al., 2010]  [148] 
 
5.2.2 Elongation  
During the process of elongation, an aa-tRNA is selected and introduced into the 
A-channel of the ribosome. This phase can only be achieved when there is a perfect match 
of the codon at the ribosomal subunit and anticodon on the tRNA. Subsequently a peptide 
bond is formed between the incoming tRNA in the A-site and the tRNA in the P-site. The 
peptidyl tRNA is displaced from the A-site to the P-site and the deacetylated tRNA from the 
P-site to the E-site 
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5.2.3 Termination 
The process of translational termination comprises the recognition of a stop codon, the 
release of the processed polypeptide chain and the dissociation of the ribosomal 
subunits. [148] 
In other words, eRF1, possessing the ability of recognizing all three stop codons, namely 
UAG, UAA and UGA, mediates the binding of eRF3 to the ribosome. Subsequently GDP 
bound to eRF3 is exchanged by GTP simultaneously with the dissociation of eRF1. 
Thereafter the process of GTP hydrolysis takes place which leads to the dissociation of 
eRF3. Finally, the ribosomal complex dissociation is mediated by the multifarious factor 
eRF3 and the ribosomal subunits are recycled and fed again into the translational 
cycle. [149] 
 
5.3 Translation Inhibition 
When cells are confronted with different types of stress, one way to overcome this situation 
is to shut down global protein synthesis. [155] The general shut-down mechanism of a cell is 
to limit the availability of ternary complexes.  Therefore the α-subunit of the eukaryotic 
initiation factor 2 is phosphorylated under stress conditions and inhibits the exchange of 
GDP to GTP, mediated by eIF2B.[156, 157] Due to the fact that eIF2B has a higher binding 
affinity to the phosphorylated than to the unphosphorylated form of eIF2α, it acts like a 
competitive inhibitor for eIF2B, which results in the persistent binding of eIF2B to the 
α-subunit. [158] Finally, this leads on the one hand to a global shut down of protein synthesis 
and  on the other hand to a concurrent translation of stress related proteins.  
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6 The ISR and their main players 
Upon sensing various kinds of stress, the routine mechanism in mammalian cells is always 
the same: shut down of the whole protein synthesis machinery (Fig. 26). Since protein 
translation is a very energy demanding process, the cell tries to save the amount of energy 
used for translation and instead reusing it for inducing stress related programs, which aids 
for the cellular surviving. [159] 
The integration of various stress signals, which modulate the protein biosynthesis, is called 
the “Integrated Stress Response” (ISR). This mode of action is conserved from yeast to 
mammals. [159] The causes for stressed cells to initiate the ISR can be very different and 
the recognition mechanisms are well designed. Four different kinases exist in the 
mammalian cell, which all share a homologous kinase domain but differ in the regulatory 
domains for initiating the integrated stress response (Fig. 27). [160, 161] 
 
 
Fig. 26: The integrated stress response and its downstream signaling molecules [Novoa et al., 2001][162] 
 
Upon sensing double-stranded RNA, especially during a viral infection, protein kinase R 
(PKR) is activated and initiates the intracellular stress program. [163]  
The endoplasmic reticulum (ER) resident transmembrane eIF2α kinase (PERK) possesses 
the ability to sense cellular stress triggered through malfolded proteins. In this situation the 
load of newly synthesized proteins is bigger than the capacity of the ER to process the 
correct folding, therefore the global shutdown of protein synthesis assists the organelle to 
overcome protein load and decrease ER stress. [164-167]  Amongst the three other eIF2α 
kinases, which all are cytosolic, PERK is the only kinase which is located at the ER 
membrane. [168] 
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In the erythroid lineage the stress sensor HRI (Heme-regulated eIF2α kinase) triggers 
cellular reaction upon stress. It possesses the ability to sense heme deficiency, particularly 
during the development of cancerous tissue. [169, 170]   
The last, and for this work most important eIF2α kinase, is the general control 
non-derepressible 2 (GCN2). Its activation is triggered upon sensing nutritional stress, or 
more specific, amino acid deprivation. [171, 172] 
Generally, the initiation of the ISR does not necessarily mean that the cell has to undergo 
apoptotic cell death. The phosphorylation of eIF2α upon ER stress sensing and activation 
of PERK is rapidly reversible within minutes when the cellular stress declines. Only if the 
stress situation persists, proapototic signal molecules are translated and directs the whole 
system towards an apoptotic course. This means that cells have to hold a sensitive 
balance between un- and phosphorylated eIF2α. [173, 174] 
 
eIF2α
eIF2α (P)
Viral Infection
PKR
ER Stress
PERK
Heme
Deficiency
HRI
Nutrient
Limitation
GCN2
eIF2B
eIF2-GDP eIF2-GTP
Translation Initiation  
Fig. 27: Stress inducers and their sensor mechanisms [modified from Sikalidis et al., 2011] [175] 
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6.1 General Control Non-derepressible 2 
The general control non-derepressible 2 (GCN2) is a serine/threonine protein kinase and 
belongs to the eIF2α kinase superfamily. The around 180 kDa big GCN2 comprises 
various conserved structures like the histidyl-tRNA synthetase (HisRS)-related domain, a 
protein kinase domain (KD) and a pseudo-protein kinase domain (ψKD) of unknown 
function. Additionally the structure also contains an N-terminal binding site for the 
GCN1/GCN20 complex, which plays a pivotal role in recognition of a starvation signal, 
which finally acts on the adaption of cell growth and differentiation. (Fig. 28) [176-178] 
 
  
Fig. 28: Protein structure of human GCN2 [Rostovskaia et al., 2003] [179] 
 
GCN2 was first identified as an inducer of GCN4 in budding yeast, though it holds a major 
role in the mammalian system concerning the stress response upon amino acid 
deprivation. [179] Saccharomyces cervisiae is known to hold the capacity of synthesizing all 
20 essential amino acids, especially upon starvation conditions. The sensor for lacking 
essential amino acids was shown to be GCN2, binding uncharged tRNA to its histidyl-tRNA 
synthetase (HisRS)-like domain, as in the mammalian system. [176, 180-182]  
An essential amino acid, of which nine exist in the mammalian system, is, per definition, an 
amino acid which is required for a healthy diet and can’t be stored and synthesized 
de novo in the human body, meaning they must be supplied by ingested diet. [183] It has 
been shown that lacking essential amino acids elicits defense mechanisms in e.g. 
omnivorous, namely developing a taste aversion or regulating fatty acid homeostasis in the 
liver. [184, 185]      
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Upon diverse forms of stress, e.g. amino acid deprivation, uncharged tRNAs bind to the 
(HisRS)-related domain of GCN2 leading to the activation of the proximate KD domain. 
Upon this change in activation status, GCN2 is able to initiate the phosphorylation of eIF2α, 
thus inhibiting eIF2B, which leads to increased translation of GCN4 in yeast and ATF4 in 
the mammalian system (Fig. 29). [176, 178] 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 29: GCN2 as a mediator in response to amino acid starvation (Modified from Dever and Hinnebusch, 2005) [176] 
 
Up to now it is clear that in the mammalian system the GCN2 pathway is essential for a 
response to amino acid starvation, but not solely being responsible for the adaption to 
nutrient deprivation. It is speculated that the mTORC1 pathway could also be involved in a 
GCN2 independent manner during the response to amino acid deprivation, at least in the 
murine system. [183]  
 
6.2 Eukaryotic initiation factor 2 
The eukaryotic initiation factor 2 (eIF2) is the effector molecule, at which all stress 
responsive pathways converge. Hence, it marks the rate limiting step in the maintenance of 
protein translation upon several different stimuli. [186] In other words, the phosphorylated 
form of eIF2 is able to inhibit protein synthesis under stress situations, thus holding a 
crucial role in cellular energy conservation and. [155, 168] 
ATF4 
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The eukaryotic initiation factor 2 was first discovered over 35 years ago as a GTP-bound 
protein associated with the initiator t-RNA. [187]    
The protein consists of three subunits, which increase in molecular mass: the α-, the β- and 
the γ-subunit (Fig. 30).  
The α-subunit of eIF2 holds a major role in the translational mechanism. It is the only 
subunit, which can be phosphorylated at the Ser51 position, which acts as a phosphate 
acceptor. As afore mentioned, various stress sensors (PKR, PERK, HRI, GCN2) are able 
to phosphorylate and therefore initiate a stress related program, which leads the cell either 
into adaptive or apoptotic programs. [168, 188] 
The β-subunit of the eIF2 comprises several phosphorylation sites. [189] Moreover it 
contains guanine nucleotide binding domains, a binding site for eIF5 on the N-terminal 
portion and a binding site for the nucleotide exchange factor eIF5B on the C-terminal 
portion. [190, 191] However since the nucleotide binding domains on the N-terminus of the 
protein are located more distant from each other than usual, it seems that the β-subunit 
doesn’t seem to be that important for guanine nucleotide binding. [192] 
The primary amino acid sequence of the γ-subunit of eIF2 comprises three consensus 
guanine nucleotide domains. This implicates that the γ-subunit is more involved in guanine 
nucleotide binding than the β-subunit. [186, 192] 
 
 
Fig. 30: Domain structure of α-, β- and γ-subunit of eIF2: The number of amino acids is depicted on the right side, the boxes represent 
the polypeptide chains, black bars indicate nucleotide binding domains [Kimball, 1999] [186] 
 
 A – INTRODUCTION 
- 45 - 
Structural analysis revealed that the amino acid sequences of eIF2 are highly conserved 
among different species. The eukaryotic initiation factor 2 in humans and Saccharomyces 
cervisiae share a homology of 58%, 47% and 72% for the  α-, β- and γ-subunit, 
respectively. [193] This sequence homology again underscores the importance of this factor 
for cell viability. [186] 
 
6.2.1 Biological function of eIF2 
The primary function of eIF2 is to mediate the transfer of the initiator t-RNA (Met-rRNAi) to 
the 40S ribosomal subunit to assemble with various other initiation factors for building the 
preinitation complex (Fig. 31). Simplistically spoken, eIF5 binds to the complex and starts 
the hydrolysis of GTP. Finally eIF2 bound to GDP is released [187, 194] 
After this process, GDP bound to eIF2 has to be exchanged to GTP, which is mediated via 
eIF2B, such that eIF2 can be implemented and reused in another initiation cycle. [186, 187] 
 
 
Fig. 31: Biological function of eIF2 [Kimball, 1999] [186] 
 
6.3 Activating Transcription Factor 4 
Activating transcription factor-4 (ATF-4) is a 39 kDA big leucine zipper transcription factor 
which belongs to the family of the basic-region leucine zippers. ATF-4 is also known as 
cAMP-response element binding protein-2 (CREB-2) or Tax-responsive enhancer 
element-binding protein 67. Up to now two alternative splicing variants of ATF-4 are 
known.[195] The ATF-4 gene is located on chromosome 22, which is translated into the 
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ATF-4 mRNA. This mRNA comprises three short open reading frames (uORFs) in the 
5’region and an adjacent coding sequence (Fig. 32). The uORFs were shown to play a 
pivotal role in the response to ER stress and hypoxia. [196] 
 
Fig. 32: Human ATF-4 mRNA sequence [Ameri and Harris, 2007] [197] 
 
The ATF-4 protein comprises 351 amino acids, which form motifs especially influencing 
homo/heterodimerization, DNA binding and regulation of ATF4 protein stability. Additionally 
a transcriptional activation domain is included in the N-terminus of the protein (Fig. 33). [198, 
199] 
 
Fig. 33: Protein structure of human ATF-4 [Ameri and Harris, 2007] [197] 
 
ATF-4 is able to interact and form homo- and heterodimers with various binding partners, 
such as members of the AP-1, C/EBP- and C/EBP-family proteins, inter alia CHOP. [200-203] 
ATF-4 can additionally be posttranslationally modified, since ATF-4 comprises a 
recognition motif for βTrCP, which binds to this region, when phosphorylated, and leads to 
proteasomal degradation of ATF-4. Contrary to this transaction, the histon acetyltranserase 
p300 is able to inhibit the degradation process by stabilizing ATF-4. [204, 205] 
ATF-4, which acts as a stress responsive gene, plays a pivotal role in amino acid 
deprivation, ER stress response and oxidative stress. [174, 206, 207] 
Under stressed conditions the eukaryotic initiation factor 2α is phosphorylated which leads 
to a global inhibition of translation, while inducing specifically the translation of ATF-4 
mRNA (Fig. 26). [196] 
What exactly happens in a nonstressed and stressed condition in the murine system is 
depicted in Fig. 34. In unstressed conditions eIF2-GTP-Met-tRNAi ternary complexes are 
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abundant, meaning that the 40s ribosome catches a ternary complex for the translation of 
uORF1 and resumes scanning to uORF2. Given that there are enough complexes 
available, the 40S ribosome can acquire a new ternary complex in time for the translation 
of uORF2.  
When the cell encounters a stress situation, e.g. after thapsigargin treatment, the whole 
protein translation machinery will be shut down, resulting in a ternary complex deficiency. 
Consequently the 40S ribosome is able to acquire a ternary complex when translating 
uORF1 and resumes scanning for uORF2. Due to the lack of ternary complexes, a new 
complex will not be available in time when the ribosome reaches uORF2. The ribosome 
then passes over uORF2, but will acquire a new ternary complex when reaching the ORF 
of ATF-4, thus translating the stress protein. [148]  
 
 
Fig. 34: Translational control of ATF-4 under nonstressed and stressed conditions [Jackson et al., 2010] [148] 
 
Overall ATF-4 seems to hold a crucial role, at least in the murine system, in various 
biological processes like eye development, cellular proliferation, hematopoiesis, bone 
development, fertility, long term memory storage and synaptic plasticity, revealed through 
knockout mouse studies. [197, 208-212] Interestingly ATF-4 seems to contribute to the 
development of cancer, since it induces VEGF an E-selectin expression, which is 
correlated with increased metastasis. [206, 213]       
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6.4 C/EBP Homologous Protein 
The CHOP gene encodes a C/EBP homologous protein, also known as CHOP10, 
GADD153 (growth-arrest- and DNA-damage-inducible gene 153), DDIT3 
(DNA-damage-inducible transcript 3) or C/EBPζ which is tightly regulated by various stress 
factors in human and mouse cells. [214] CHOP, a 29 kDa protein which comprises 169 
amino acid residues in the human system and 168 amino-acid residues in rodents, holds a 
pivotal role in immune functions, cell differentiation and proliferation. [215, 216] This nuclear 
protein was originally identified to be induced upon DNA damage and is capable to form 
heterodimers with various members of the C/EBP family [215], which are then able to identify 
target DNA sequences. [214, 217]  
CHOP is composed of two functional domains, the N-terminal transcriptional activation 
domain and the C-terminal basic-leucine zipper (bZIP) domain, comprising an amino acid 
rich area for DNA binding and a leucine zipper dimerization motif (Fig. 35).  
 
 
Fig. 35: Domain structures of CHOP [Oyadomari and Mori, 2004] [216] 
 
Interestingly, CHOP is not solely controlled on transcriptional and translational level, but 
also by post-translational phosphorylation on serine 78 and 81 via p38 MAPK. [218] 
Some years ago it was discovered that the CHOP promoter contains an amino acid 
response element (AARE), which displays an important binding motif for the transcription 
factor ATF4 in the amino acid response, which highlights the importance of CHOP as an 
ATF4 downstream target (Fig. 26). [218, 219] Additionally the promoter also includes two ER 
stress response elements (ERSE-1, ERSE-2), which are located in opposite directions and 
mediate the cellular response upon ER stress (Fig. 36). [220, 221] The ERSE elements of the 
CHOP promoter show a high sequence homology to the ERSE elements on the promoter 
regions of BiP, GRP94, PDI and CRT (Calreticulin). A weak homology is found for the 
CHOP AARE sequence when comparing with C/EBP- and ATF-binding sites. [222]  
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Fig. 36: Structure of the CHOP promoter with amino acid response elements (AARE) and ER stress response elements (ERSE) 
[Oyadomari and Mori, 2004] [216] 
CHOP is concomitantly expressed with the ER chaperone BiP [223-225] and can either be 
induced by direct [226-228] or indirect [229-231] stress response agents, which lead to an 
impairment in folding capacity in the ER. Some examples of ER stress inducing drugs are 
tunicamycin (glycosylation blocker), thapsigargin (calcium ATPase inhibitor specific for the 
ER), A23187 (calcium ionophore) and dithiothreitol (DTT; disruption of disulfide bonds). [228] 
The group around Zinszer et al. identified in 2003 that CHOP holds a major role in 
programmed cell death since CHOP-/- MEFs show increased cellular viability compared to 
wt cells when challenged with ER stress inducing toxin. [214] The contribution to 
programmed cell death is, inter alia, achieved through downregulating BCL2 and 
upregulating GADD34, ERO1α and TRB3. [218]  
CHOP is endogenously expressed in the cytosol at extremely low levels under nonstressed 
conditions. However, if stress is induced in the cell, CHOP translocates from the cytosol to 
the nucleus and accumulates there. [215] 
Overall CHOP is considered to be involved in the development of several diseases like 
diabetes, brain ischemia and neurodegenerative diseases as a result of aggregated 
proteins in the ER. In diabetic conditions, prolonged ER-stress leads to apoptosis of β-cells 
via CHOP, CHOP mediates ER-stress in vulnerable neurons which leads to delayed cell 
death and in the case of neurodegenerative diseases like Parkinson’s, Alzheimer’s or 
Huntington’s disease, CHOP mediates apoptosis upon malfolded proteins. [216, 232]  
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7 Alternative Pathways for the Adaption to Nutrient 
Deprivation 
7.1 Autophagy 
Autophagy has been described as the process of degradation of intracellular components. 
[233, 234] Generally three types of autophagy exist: (i) macroautophagy (ii) microautophagy 
and (iii) chaperone-mediated autophagy. In this thesis, autophagy is used for the term of 
macroautophagy. Autophagy can additionally be divided into two distinct systems: (i) the 
non-selective degradation system and (ii) the selective degradation system, which 
recognizes ubiquitinated proteins. [235]  
Autophagy has several important roles comprising adaption to starvation, degradation of 
intracellular proteins and organelles, development, anti-aging, clearance of 
microorganisms, cell death mediation, tumor suppression and antigen presentation. [235, 236]  
Mizushima described in 2005 that the extent of autophagy is tightly regulated and can 
range from “basal autophagy”, which includes the turnover of intracellular components, and 
“induced autophagy”, which is initiated upon stress induction for gaining new energy 
supply. [236] 
Autophagy is highly conserved upon yeast, plants and animals and consists of several 
consecutive steps (Fig. 37). 
The first step in the induction of autophagy is the building of a phagophore (also called 
isolation membrane), which looks like a Golgi cisternae. Elongation of this isolation 
membrane leads to a double membraned autophagosome, where the fusion of the two 
extremities is mediated via SNARE (soluble N-ethylmaleimide-sensitive-factor attachment 
receptor) proteins. How exactly these isolation membranes are built up is, up to now, not 
clearly understood. It is believed that a so called “pre-autophagosomal structure” (PAS) 
could give rise to this complex, but no evidence was found up to now to prove this 
hypothesis. [237] After fusion with an endosome, the autophagosome associates with a 
lysosome, which enables the now called autolysosome to degrade enclosed particles.  
 A – INTRODUCTION 
- 51 - 
 
Fig. 37: Formation of an autophagosome via defined steps [Mizushima, 2007][235] 
 
The autophagic pathway can be used for several purposes: (i) simple transport tool from 
the cytoplasm to a lysosome or endosome, (ii) degradation of malfolded proteins and 
organelles and (iii) breakdown of cellular products for energy supply. [236] 
The latter point constitutes the most important function of autophagy. If a cell experiences 
stress, e.g. nutrient limitation, autophagy is induced within minutes and cellular products 
are fed into the autophagic loop to gain basic amino acids, helping the cell to overcome 
stress situations and, thus, survive. [238]  
One mammalian specific factor important for the regulation of autophagy is Beclin-1 with its 
interaction partner Bcl-2 (B-cell lymphoma 2). [239] This interaction is reduced upon 
starvation conditions, resulting in the dissociation of Beclin-1 from Bcl-2, leading to the 
initiation of autophagy. [240, 241]  
Another important autophagic protein is LC3, which was identified being located in the 
autophagosomal inner membrane. [242] LC3 is thought to act as receptor for p62/SQSTM1 
(sequestosome 1), which accumulates in autophagic cells and seems to have the ability to 
recruit ubiquitinated proteins to the autophagosomal membrane. [243, 244] Generally, two 
forms of LC3 exist: (i) LC3-I and (ii) LC3-II. Upon induction of autophagy, the cytosolic form 
(LC3-I) is cleaved and recruited to the autophagosomal membrane, where it is lipidinated, 
resulting in the smaller LC3-II form. Thus, especially the processed form LC3-II, is a 
powerful marker for autophagy. [236]      
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7.2 PI3K/mTOR Pathway 
mTOR (mammalian target of rapamycin), well known since the discovery of rapamycin in 
the 1970s, which acts as specific inhibitor for mTOR, has first been described in the yeast 
system as TOR1 and TOR2, and later the mammalian homologue was identified. [245, 246] 
mTOR, which constitutes a 1,5-2,0 MDa multiprotein complex, is a serine/threonine protein 
kinase which belongs to the family of phosphoinositide (PI)-3 kinase-related kinases 
(PIKKs). [247-249] 
mTOR plays a pivotal role in cell cycle progression, translation control, ribosomal 
biogenesis, transcription control and autophagy. [250, 251] If the cell encounters nutrient 
deprivation, e.g. through amino acid withdrawal, mTOR senses this insufficiency, which 
rapidly leads to the dephosphorylation of 4E-BP1 and S6K1 and interferes with the 
translational machinery. This means, like during the intregrated stress response, global 
protein translation is shut down, whereas stress specific mRNAs are upregulated (Fig. 38). 
[252-254] 
 
Fig. 38: Stress sensor mTOR and its downstream signaling pathway [Tee and Blenis, 2005][247] 
 
eIF4E (eukaryotic initiation factor 4E) plays a crucial role in the initiation of translation. 
Generally, eIF4E interacts with a translational protein called 4E-BP1, which normally blocks 
the formation of the translation complex. In the case of abundant nutrient supply, 4E-BP1 is 
highly phosphorylated, which leads to the dissociation from eIF4E leading to the 
completion of complex formation. If the cell experiences stress, e.g. upon nutrient 
deprivation, 4E-BP1 is rapidly dephosphorylated and the interaction between 4E-BP1 and 
eIF4E can not be broken up, thus leading to a translational stop. [252] 
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Another downstream target in the PI3K/mTOR pathway is the S6K1 (protein S6 kinase 1), 
which is as well dephosphorylated and thus inactivated upon amino acid starvation. 
Blockage through dephosphorylation of S6K1 leads to the inhibition of its substrate rpS6 
(ribosomal protein S6), which is found in the 40S ribosomal complex, affecting the 
translational process. [253] 
The third most important protein, which is affected through mTOR, is eEF2 (eukaryotic 
elongation factor 2). mTOR regulates the activity of eEF2 kinase, which phosphorylates 
eEF2, leading to the impairment of translation, resulting in reduced elongation rates. [254] 
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B - HYPOTHESIS 
The knowledge described was the basis for this project. IDO competent dendritic cells are 
known to exert immunosuppressive action on surrounding T-lymphocytes in the course of 
an allogeneic mixed lymphocyte reaction. However, this immunosuppressive effect is 
short-lived, due to the fact that upon withdrawal of IDO competent DCs and reintroducing 
these T-lymphocytes into a 2nd round allogeneic mixed lymphocyte reaction, T-cells are 
able to react against foreign lymphocytes and regain the ability of their full proliferative 
capacity. 
The immunosuppressive effect of IDO via tryptophan depletion and kynurenine 
accumulation was described to trigger the integrated stress response, and thus, being 
easily reversible upon tryptophan repletion.  
These preceding data incited our group to reveal the mechanism of the integrated stress 
response induced through tryptophan starvation and fathom the effects in the human 
system. 
Out hypothesis states that the integrated stress response, initiated via tryptophan 
starvation, proves also true for the human system and hence is the cause for the 
reversibility of tolerance induction through dendritic cells. 
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C - MATERIALS AND METHODS 
1 Isolation and purification of human peripheral blood 
mononuclear cells with subsequent enrichment of 
T-lymphocytes 
1.1 Isolation and purification of human PBMCs 
Venous blood was drawn by a medical specialist using the Vacuette® blood collection set 
(Greiner Bio One) comprising a collection set with luer adapter (#45006), heparinized 
collection tubes (#455084) and standard tube holders (#450201). After collection, 100 µl of 
whole blood were withdrawn under sterile conditions and used for analyzing the blood 
count (Sysmex KX-21N) and to ascertain any leukocyte number abnormalities. All following 
steps were conducted under sterile conditions in a laminar flow hood (Ehret, Esco Infinity 
Class II BSC). The amount of whole blood was then collected in falcon tubes and diluted 
1:1 with 1x PBS (PAA, H15-002). Up to 36 ml of diluted whole blood were then carefully 
overlayed on 14 ml LymphoprepTM (Axis-Shield, #LYS 3773) and centrifuged 
(Thermo-Scientific, Heraeus Multifuge 1S-R) at 1000 g, at 21°C for 20 min without breaks. 
After centrifugation, the interphase (Fig. 39), containing human peripheral blood 
mononuclear cells (PBMCs), was carefully transferred to a 50 ml falcon tube. PBMCs were 
then washed with 1x PBS and centrifuged at 460 g, at 4°C for 7 min.  
 
 
Fig. 39: Interphase of human PBMCs after LyphoprepTM centrifugation [Munoz and Leff, 2006][255] 
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1.2 Enrichment of T-lymphocytes via MACS (Magnetic Cell Separation) 
The supernatant was removed and the cell pellet was resuspended in 40 ml MACS 
separation buffer (see Table 1) and again centrifuged at 460 g, at 4°C for 7 min. The 
supernatant was carefully removed and the cell pellet was resuspended with 5 ml MACS 
Buffer. 100 µl were used to perform a cell count (Sysmex), whereas the total cell 
suspension was again centrifuged at 460 g, at 4°C for 7 min. Afterwards the supernatant 
was removed and the appropriate amount of MACS Buffer and Biotin labeled antibody was 
added according to the manufacturers protocol (Pan T-cell Isolation Kit II, Miltenyi Biotec, 
#130-091-156) and incubated for 10 min at 4°C. Thereupon, again an appropriate amount 
of MACS buffer and anti-biotin microbeads were added to the mixture and incubated for 
15 min at 4°C. Then 20 x volume of MACS buffer were added to the tube and centrifuged 
at 460 g, at 4°C for 7 min. Meanwhile, the MACS separation stand including a magnetic 
unit and a separation column (25 MS, MACS Miltenyi, #130-042-201) were adjusted and 
equilibrated with 3 ml of MACS buffer. The supernatant was carefully removed and the 
cells were resuspended in 500 µl up to 1*108 cells. The cell suspension then was loaded 
onto the column and separated through magnetic and gravitational forces. All non-T-cells 
were retained in the column through magnetic labeling, whereas all T-lymphocytes were 
able to pass through and were collected in a separate tube (indirect separation technique) 
(Fig. 40). The tube was washed with 9 ml MACS buffer, which was as well loaded onto the 
column for separation.  
 
 
Fig. 40: MACS T-cell enrichment technique with indirect separation [Miltenyi Biotec, 2012] [256] 
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After the separation step, T-cells were counted with the Sysmex, centrifuged at 460 g, at 
4°C for 7 min and the supernatant was removed. Finally the cell number was adjusted for 
the optimal working concentration with the appropriate medium. 
 
Buffer Compositions 
 MACS Buffer 
Running 
Buffer 
(10x) 
Blotting 
Buffer 
(10x) 
Washing 
Buffer 
Antibody 
Dilution 
Buffer 
Stripping 
Solution 
(pH 2) 
Annexin 
V Buffer
Erylysis 
Buffer 
(pH 7,2-
7,4) 
Company Product # 
Glycin  144 g 140 g   0,938 g   Roth 3908.2 
Tris Base  30 g 30 g      AppliChem A1086,1000 
SDS  10 g    5 g     
dH2O  
ad 
1000 ml 
ad 
1000 ml   
ad 
500 ml 
ad 
500 ml 
ad 
1000 ml Sigma L3771 
1x PBS 500 ml   500 ml 100 ml    PAA H15-002 
HSA 
(20 %) 12,5 ml        
CSL 
Behring 
0053-7695-
34 
EDTA 
(500 mM) 2 ml        Promega V4231 
Tween 
20    1 ml 0,2 ml    Sigma P1379 
10x 
Roche 
Western 
Blocking 
Reagent 
    5 ml    Roche 11921673001 
HEPES       10 ml  Affymetrix 16928 
NaCl       7,56 g  Roth 3957.1 
CaCl2       0,37 g  Roth CN93.1 
NH4Cl        8,024 g Roth 5470.1 
KHCO3        1 g Roth P748.2 
Na2EDTA        37,2 mg Sigma E5134 
Table 1: Buffer compositions 
 
1.3 CFSE labeling 
For proliferation studies, cells were labeled with CFSE (carboxyfluorescein succinimidyl 
ester, Sigma, # 21888-25MG-F). CFSE staining is used to assess cellular proliferation. 
When a cell divides, CFSE intensity is decreased by half and decreases with further cell 
divisions, thus indicating cell proliferation. Cells were centrifuged at 460 g, at 4°C for 7 min, 
the supernatant was removed and the cells were adjusted to 1*107/ml with CFSE-PBS 
(1x PBS, 0,1 % HSA). CFSE was added (1,5 µM) to the suspension and incubated for 
15 min at 37°C. 1 ml FBS was added to 1*107 cells (Invitrogen, #10500-064) to quench the 
reaction and the cell suspension was incubated for 2 min on ice. Afterwards tryptophan 
depleted medium was added to the suspension (10 ml per 1*107 cells) and cells were 
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centrifuged at 460 g, at 4°C for 7 min. The supernatant was removed and the washing step 
was repeated. Finally, the cell number was adjusted to the required concentration with 
either tryptophan deplete or tryptophan replete medium.      
 
1.4 T-cell culture conditions 
After adjusting the cell number, cells were plated in either 6-well (IWAKI, #3810-006), 
12-well (IWAKI, #3815-048), 24-well (IWAKI, #3820-024) or 96-well (Nunc, #163320) 
plates with Tryptophan deficient medium (PAA, #T1144,2500) or Tryptophan sufficient 
medium (PAA, #E15-840) both supplemented with 1% Glutamine (PAA, #M11-004), 
1 % Penicillin/Streptomycin (PAA, #P11-010) and either 1 %, 5 % or 10 % tryptophan 
deplete FBS (PAA, #A11-107) to ascertain cell culture conditions fully deplete of 
tryptophan. 
Cells were simulated either with 50 ng/ml PMA (phorbol-12-myristate-13-acetate, Sigma, 
#P1585-1MG) and 500 ng/ml Ionomycin (Sigma, 10634-1MG) or a monoclonal anti-CD3 
(Sigma, #C7048-100TST) and anti-CD28 (Sigma, #C7831-100TST) antibody after plate 
precoating with anti-Mouse IgG1 (Sigma, #M8770). 
To increase stress conditions in vitro, cells were stimulated with thapsigargin (Sigma, 
#T9033). Thapsigargin is a non-competitive calcium pump inhibitor in the endoplasmic 
reticulum, thereby depleting the ER from calcium and leading to the raise in cytosolic 
calcium concentration.   
The Jurkat T-cell line was obtained from the DSMZ (Deutsche Sammlung von 
Mikroorganismen und Zellkulturen, #ACC282) and maintained in Gibco® RPMI 1640 
medium (Invitrogen, 21875-034) supplemented with 1 % Glutamine, 1 % Pen/Strep and 
10 % FBS before use. Since Jurkat cells have a doubling time of 25-35 hours, cells were 
split at an optimal ratio of 1:2 to 1:3 every 2 to 3 days.  
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2 Isolation and purification of murine splenocytes 
Spleens were harvested from C57BL/6 or BALB/c mice and subsequently singularized 
using a 70 µM cell strainer (Becton Dickinson, #352350), while flushing the single cells with 
RPMI 1610, supplemented with 1 % Glutamine, 1 % Pen/Step and 10 % dialyzed FBS, into 
a falcon tube. The cells were then centrifuged at 460 g, at 4°C for 7 min, the supernatant 
was removed and 1 ml erylysis buffer (see Table 1) per spleen was added, mixed well and 
incubated on ice for 1 min. The lysis process was stopped by adding 40 ml MACS Buffer 
(see section 1.2) and cells were again centrifuged at 460 g, at 4°C for 7 min. The 
supernatant was again removed, the pellet was resuspended in 5 ml MACS Buffer and a 
cell count was performed with the Z2 Coulter Counter (Beckman Coulter).  
 
2.1 Enrichment of murine T-cells via MACS separation 
T-cells were enriched as human T-cells (see section 1.2) with a mouse Pan T Cell Isolation 
Kit II (Miltenyi, #130-095-130) according to the manufacturer’s protocol. 
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3 Sample Preparation  
3.1 Protein samples 
Cells were harvested by transferring the cell suspension in a tube and flushing the wells 
with 1x PBS, which was also transferred to the tubes. The cells were then centrifuged at 
460 g, at 4°C for 7 min, the supernatant was removed, and the pellet was resuspended 1:1 
with 1x PBS and 2x Novex® Tris-Glycine SDS Sample Buffer (Invitrogen, #LC2676). 
Before, the sample buffer was supplemented with 3% Dithiothreitol (Sigma, #43815-1G). 
The samples were then heated (Eppendorf, Thermomixer Compact) to 99°C for 10 min and 
stored until usage at -80°C. 
 
3.2 RNA samples 
3.2.1 RNA isolation 
RNA was isolated with a QIAShredder® (QIAGEN, #79654) and the RNeasy® Mini Kit 
(QIAGEN, #74104) according to the manufacturer’s instructions (RNeasy® Mini Handbook, 
“Purification of Total RNA from Animal Cells Using Spin Technology”). RNA concentration 
was determined by measurement of 1 µl with Nanodrop (Thermo Scientific, ND-1000). 
Finally all samples were adjusted to equal concentrations (1 µg/20 µl) with nuclease free 
H2O (Fermentas, #R0581) and stored at -80°C until being used.  
 
3.2.2 Reverse transcription 
1 µg of isolated RNA was transferred into an RNAse and DNAse free tube and heated at 
65°C for 15 min. Then 4 µl M-MLV RT-5X Buffer (Promega, #M531A), 2 µl 100mM DTT 
(Invitrogen, #Y00147), 1 µl Random Primers (Promega, #C118A), 1 µl 10mM dNTPs 
(Promega, #U120A, #U121A, #U122A, #U123A), 1 µl nuclease free H2O and 1 µl M-MLV 
Reverse Transcriptase (Promega, #M170B) were added and the samples were incubated 
at 37°C for 90 min. Finally the cDNA (complementary DNA) was stored at -80°C until 
usage.  
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3.3 Flow cytometric samples 
100 µl of cell suspension were transferred to plastic tubes, diluted with 100 µl Annexin V 
Buffer (see Table 1) and the antibody cocktail was added (Table 2). The suspension was 
then incubated for 20 min in the dark at 4°C and analyzed by flow cytometry (see section 0) 
Antibody Fluorochrome Specificity Company Catalog 
number 
Dilutions 
CD25 PE-Cy7 Mouse-
anti-human
Becton 
Dickinson
#557741 1:500 
CD3 PE-TxRed Mouse-
anti-human
Becton 
Dickinson
#624004 1:500 
CD4 FITC Mouse-
anti-human
Dako #F0766 1:200 
CD8 RPE Mouse-
anti-human
Dako #R0806 1:2000 
Annexin 
V 
APC Unspecific Becton 
Dickinson
#550474 1:200 
Dapi Dapi Unspecific Sigma 
Aldrich 
# 9542-1MG 1:100 (of 
0,03 µg/ml 
stock) 
Table 2: Flow cytometric antibodies and respective dilutions 
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4 Analyses Methods 
4.1 Protein analyses 
4.1.1 SDS PAGE 
Samples were thawed and heated to 99°C for 10 min. In the meantime, either 10 % SDS 
PAGE gels were prepared (Table 3) or 4–20% Mini-PROTEAN® TGX™ Precast Gels 
(Bio-Rad, #456-1094) were arranged in the Mini PROTEAN® Tetra Cell chamber (Bio-Rad, 
#165-8000). The gels were run constantly at 80 V for 20 min (for running buffer see Table 
1), until the loading dye band has passed the border between stacking and separating gel. 
The protein size was estimated using the PageRuler® Plus Prestained Protein Ladder 
10-250 kDa (Thermo Scientific, #26619) and CHOP expression was monitored via a CHOP 
Lysate (Santa Cruz Biotechnology, #sc-120383). Then the voltage was increased to 150 V 
and run for 90 min. Finally the gel pack was disassembled and the gel was blotted. 
 
 
Separating Gel Stacking Gel 
dH2O 4,9 ml dH2O 3,4 ml 
30 % 
Acrylamide/ 
0,8% Bis 
4 ml 
30% 
Acrylamide/ 
0,8% Bis 
830 µl 
1,5 M Tris pH 
8,8 3 ml 
1 M Tris pH 
6,8 630 µl 
20% SDS 60 µl 20% SDS 25 µl 
APS 120 µl APS 50 µl 
TEMED 14,4 µl TEMED 5 µl 
Table 3: Composition of SDS PAGE separating and stacking gel 
 
4.1.2 Western blotting 
The SDS PAGE gel was blotted (for blotting buffer see Table 1) onto a PVDF membrane 
(Bio-Rad, #162-0177) at 300 mA for 60 min. If mTOR (see section 7.2) was going to be 
analyzed, the gel was cut between 100-130 kDa before blotting and blotted at 300 mA for 
120 min. After the blotting procedure, the membrane was cut to the area of interest and 
blocked with 1x (diluted with 1x PBS) Western Blocking Reagent® (Roche, #11921673001) 
for 60 min with shaking on RT. Then the blot was incubated in primary antibody solution 
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(Table 4) at 4°C with shaking o/n. On the next day the blot was washed three times in 
washing buffer (see Table 1) for 5 min and then incubated in secondary antibody solution 
(Table 4) for 1 h. The developing analysis was performed with the ODYSSEY® CLx imager 
(Li-cor Bioscience) and analyzed with the image quantification system ImageJ 
(NIH Image).  
 
Antibody Company Product Number Dilution/ 
Concentration 
Primary Antibodies    
peIF2α Cell Signaling 
Technology 
#9721S 1:500 
eIF2α Cell Signaling 
Technology 
#9722S 1:500 
CHOP Santa Cruz 
Biotechnology 
#sc-7351 1:100 
LC3 nanoTools #0231-100/LC3-5F10 1,5 µg/ml 
Beclin-1 Santa Cruz 
Biotechnology 
#sc-11427 1:400 
SQSTM1/p62 Cell Signaling 
Technology 
#8025 1:500 
pmTOR Cell Signaling 
Technology 
#2971 1:600 
mTOR Cell Signaling 
Technology 
#2972 1:850 
prpS6 Cell Signaling 
Technology 
#2215 1:700 
α-Tubulin Calbiochem #CP06 1:1000 
GAPDH Ambion Life 
Technologies 
#AM4300 1:10 000 
Secondary Antibodies    
Goat anti-Mouse IgG (H+L) 
(DyLight 800), Polyclonal 
Thermo Scientific #35521 1:10 000 
Goat anti-Rabbit IgG (H+L) 
(DyLight 800), Polyclonal 
Thermo Scientific #35571 1:10 000 
Table 4: Primary and secondary antibodies with respective working dilutions 
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4.2 RNA analyses 
4.2.1 Real time PCR 
Primers were designed (Table 5) and ordered at Eurofins MWG Biotech with HPSF 
purification and 0,01 µmol synthesis scale.  
 
Gene Gene Bank 
Accession # 
Species Fwd Sequence (5’-3’) Rev Sequence (5’-3’) 
GAPDH NM_002046 Human AAGGTGAAGGTCGGAGTCAAC GGGGTCATTGATGGCAACAATA 
eIF2α NM_004094 Human TGGTGAATGTCAGATCCATTGC TAGAACGGATACGCCTTCTGG 
ATF4 NM_182810 Human CTCCGGGACAGATTGGATGTT GGCTGCTTATTAGTCTCCTGGAC 
CHOP NM_001195055 Human GAACGGCTCAAGCAGGAAATC AGTCGCCTCTACTTCCCTGG 
Table 5: Investigated genes with respective forward (fwd) and reverse (rev) primer sequences 
 
The mastermix was prepared by adding 10 µl Maxima™ SYBR Green/ROX 2X qPCR 
Master Mix (Fermentas, #K0221), 3 µl nuclease free H2O and 2 µl of a 10 pmol primer mix 
(forward and reverse). 10 µl of this mastermix were added to a MicroAmp® Fast Optical 
96-Well Reaction Plate 0.1 ml (Applied Biosystems, #4346906), while cooling the plate with 
ice. cDNA was thawed and diluted with nuclease free H2O to a concentration of 1,5 ng/ml. 
5 µl were added to the reaction plate which was finally sealed with a MicroAmp® Optical 
Adhesive Film (Applied Biosystems, #4311971). The reaction included two holding stages 
(50°C and 95°C for 2 min and 10 min respectively), 40 cycles (95°C heating for 15 sec, 
60°C cooling for 1 min) and a melting curve stage (95°C for 15 sec, 60°C for 1 min, 95°C 
for 30 sec) with a total duration time of approximately 120 min. Obtained results were then 
analyzed and calculated, in consideration of the primer efficiency (Formula 1), using the 
“efficiency corrected calculation model” (Formula 2). [257]  
 
Formula 1: Efficiency calculation according to Pfaffl, 2006[257] 
 
 
Formula 2: Efficiency corrected calculation model [Pfaffl, 2006] [257] 
 
4.3 Flow cytometric analyses 
Expressed cell surface markers were measured by flow cytometry (Becton Dickinson, 
LSR2) and analyzed with FlowJo (Tree Star).  
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1 The Integrated Stress Response and Autophagy Induction 
in the murine system 
1.1 Optimal culture conditions for murine splenocytes 
The background for this study was to investigate whether previous findings by Munn et al. 
in 2005, which state that the induction of the integrated stress response is strongly 
correlated with tryptophan starvation in mice [4], are also valid for the human system. Prior 
to the investigation of the ISR in the human system, the aim was to reproduce these 
published results in murine cells.  
In order to ascertain that a high apoptotic decline does not interfere with the detectability of 
ISR induction, the rate of apoptosis was assessed in different culture conditions. 
For this purpose, BALB/c or C57BL/6 splenocytes (3*106 and 4,5*106) were activated with 
PMA/Ionomycin and cultured in TRP deplete or TRP replete medium, supplemented with 
1 % or 10% TRP free serum, for 24 h. We reasoned that to detect the initiation of the ISR, 
cells should have limited access also to other nutrients. This means that sufficient, but not 
abundant nutrient should be supplied in the culture. This was the rational to probe 
increasing serum concentrations for medium supplementation. Additionally, cells were 
stimulated with 1 µM thapsigargin (TG) for up to 4h. [159, 167, 174, 196, 214, 258] 
As depicted in Fig. 42, the susceptibility to apoptosis in murine splenocytes, cultured in 1 % 
TRP free serum, was elevated indicated by the high proportion of 70-80 % apoptotic cells.   
Cellular survival was markedly increased to approximately 90 % upon supplementation of 
10 % TRP free serum (Fig. 43). In this cell culture condition, neither stimulation with 1 µM 
TG nor activation with PMA/Ionomycin increased apoptosis in murine splenocytes even for 
4 h.  
Thus for further experiments, cell cultures were maintained in TRP deplete or replete 
medium supplemented with 10 % TRP free serum.  
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Fig. 41: Dotplot of murine splenocytes maintained under suboptimal culture conditions 
Gating strategy for Annexin V / DAPI staining for detection of apoptosis in resting murine splenocytes (3*106), cultured in TRP free 
medium supplemented with 1 % TRP free serum and stimulated with TG (1 µM) for 1 h 
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Fig. 42: Susceptibility to apoptosis of murine splenocytes maintained under suboptimal culture conditions 
Apoptotic rate of murine splenocytes (3*106) cultured for 24 h in TRP free or TRP containing medium supplemented with 1 % TRP free 
serum and challenged with thapsigargin (TG, 1 µM) for up to 4h 
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Fig. 43: Susceptibility to apoptosis of murine splenocytes maintained under optimal culture conditions 
Apoptotic rate of resting murine splenocytes (4,5*106) cultured in TRP free medium supplemented with 10 % TRP free serum and 
stimulated with TG (1 µM) for up to 4h   
TRP deplete TG (1µM, 1h) 
TRP deplete TG (1µM, 1h) TRP deplete TG (1µM, 1h) 
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1.2 Initiation of the integrated stress response in murine splenocytes 
upon tryptophan starvation 
Munn et al. showed in 2005 that the ISR stress protein CHOP was expressed by 
tryptophan withdrawal in PMA/Ionomycin activated murine splenocytes. [4] This experiment 
aimed for reproducing these findings.  
Murine splenocytes (7*106) were activated with PMA/Ionomycin and cultured in either TRP 
deplete or TRP replete medium, supplemented with 10 % TRP free serum, for 24 h. The 
integrated stress response was monitored via phosphorylation of eIF2α and CHOP 
expression.  
Our results show (Fig. 44 and Fig. 45) that CHOP expression was not detected in murine 
splenocytes. Since no CHOP band was detectable in the positive CHOP lysate control, we 
suggest that the antibody was not appropriate for detection.  
However, activation through PMA/Ionomycin was shown to trigger enhanced expression of 
phosphorylated eIF2α (Fig. 44). The quantification by densitometric analysis revealed a 
1,28-fold increase in activated cultures maintained in TRP deplete or TRP replete culture 
medium (Fig. 45 and Table 6). Remarkably, no difference in phosphorylation of eIF2α was 
noted, neither in resting nor in activated cells cultured in TRP deplete compared to TRP 
replete medium (Fig. 45 and Table 6). Likewise, endogenous eIF2α levels increased 1,2 to 
1,3-fold upon activation, but again no difference was observed comparing TRP deplete to 
TRP replete conditions. These findings suggest a non specific upregulation of protein 
expression upon activation with PMA/Ionomycin. These observations are in marked 
contrast to published data by Munn et al. and indicate that the ISR is not initiated in murine 
splenocytes. 
However, increased protein expression through stimulation with PMA/Ionomycin was 
though specific for stress related proteins, since marker protein expression for autophagy 
was not affected upon stimulation (see section 1.3). 
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Fig. 44: ISR marker protein expression in murine 
splenocytes 
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Fig. 45: Densitometric analsysis of ISR associated marker 
proteins 
Numbers indicate the fold increase of activated versus resting and 
TRP deplete versus TRP replete ratios 
 
peIF2α Resting Activated Fold increase 
 trp 
deplete 
trp deplete 1,28 
 trp 
replete 
trp replete 1,28 
Fold increase 0,92 0,92  
 
eIF2α Resting Activated Fold increase 
 trp 
deplete 
trp deplete 1,30 
 trp 
replete 
trp replete 1,20 
Fold increase 0,93 1,00  
Table 6: Fold changes of ISR protein expression upon maintenance in TRP deplete or TRP replete culture medium and 
activation with PMA/Ionomycin
Fold changes were calculated by dividing TRP deplete by TRP replete ratios 
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1.3 Assessment of autophagy in murine splenocytes upon tryptophan 
starvation 
Because our investigations did not find ISR induction by tryptophan starvation in murine 
cells, as alternative pathway involved in cellular adaption to nutrient deprivation, 
autophagy, was analyzed. Like before, murine splenocytes (7*106) were activated with 
PMA/Ionomycin and cultured in either TRP deplete or TRP replete medium, supplemented 
with 10 % TRP free serum, for 24 h. Autophagy induction was analyzed by Beclin-1 and 
p62/SQSTM1 protein expression.  
Levels of expression of Beclin-1 and p62/SQSTM1 (Fig. 46 and Fig. 47) were not affected 
by activation, which is illustrated by only minimal fold changes as shown in Table 7. 
Different from proteins involved in the ISR, activation with PMA/Ionomycin did not enhance 
Beclin-1 or p62/SQSTM1 expression in cells. Moreover, levels of Beclin-1 and 
p62/SQSTM1 were not increased in TRP free culture conditions (Table 7). These data 
suggest that autophagy is not triggered upon TRP starvation in murine splenocytes. 
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Fig. 46: Autophagy in murine BALB/c splenocytes 
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Fig. 47: Densitometric analsysis of autophagy associated marker 
proteins 
 
Beclin-1 Resting Activated Fold increase 
 TRP deplete TRP deplete 1,02 
 TRP replete TRP replete 1,03 
Fold increase 0,91 0,90  
 
p62/SQSTM1 Resting Activated Fold increase 
 TRP deplete TRP deplete 1,01 
 TRP replete TRP replete 1,16 
Fold increase 1,01 0,88  
Table 7: Fold changes of autophagy marker protein expression in murine splenocytes maintained in TRP deplete or TRP 
replete culture medium and activated with PMA/Ionomycin
Fold changes were calculated by dividing TRP deplete by TRP replete or activated by resting ratios  
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2 The Integrated Stress Response and Autophagy Induction 
in the Jurkat T-lymphocyte cell line 
2.1 Characterization of Jurkat T-lymphocytes 
The Jurkat T-cell line has been widely used as a model system deciphering the induction of 
the ISR. [259, 260] In our study, this cell line was used initially to explore a potential effect of 
TRP starvation on the induction of the ISR in human cells. First, for characterization of 
Jurkat cells, susceptibility to apoptosis and activation status was investigated via 
monitoring Annexin V / DAPI and CD25 surface expression, respectively. Jurkat 
T-lymphocytes (1*106) were activated with PMA/Ionomycin and cultured either in TRP 
deplete or TRP replete medium, supplemented with 1 % or 10 % TRP free serum, for 24 h. 
Afterwards, cells were stimulated with either 1 µM or 10 µM TG for up to 4 h, to determine 
the maximal dose and time of TG, which is tolerated by cells. 
As Fig. 48  shows, apoptosis was slightly increased by up to 18 % upon maintenance in 
TRP deplete culture medium supplemented with only 1 %, in comparison to cultures 
supplemented with 10 % TRP free serum (Fig. 49), represented by only 8 % apoptotic 
cells. Even prolonged exposure to high (10 µM) concentrations of TG did not further 
enhance susceptibility to apoptosis (Fig. 48). Similarly, the survival of these cells was no 
decreased in TRP free cell culture conditions.  
Overall, Jurkat T-cells appeared very robust when cultured under suboptimal culture 
conditions (low serum concentrations, TRP deprivation, prolonged high concentrated TG 
stimulation). 
Further, the cell activation marker CD25 was shown to be permanently expressed on 
Jurkat T-cells, suggesting that they are constitutively activated (Fig. 50).   
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Fig. 48: Apoptotic response of Jurkat T-lymphocytes maintained in culture medium supplemented with 1 % TRP free serum 
(A) Representative Annexin V / DAPI staining dotplot of resting human Jurkat T-cells cultured in TRP free medium and stimulated with 
1 µM TG for 1 h; (B) Susceptibility to apoptosis of human Jurkat T-cells cultured in TRP deplete and TRP replete medium and stimulated 
with TG (1 µM, 10 µM, 1h)  
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Fig. 49: Apoptotic response of Jurkat T-lymphocytes maintained in culture medium supplemented with 10 % TRP free serum 
(A) Representative Annexin V / DAPI staining dotplot of resting human Jurkat T-cells cultured in TRP free medium and stimulated with 
1 µM TG for 1 h; (B) Susceptibility to apoptosis of human Jurkat T-cells cultured in TRP deplete and TRP replete medium and stimulated 
with TG (1 µM, 1h, 4h)  
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Fig. 50: CD25 surface expression on Jurkat T-cells
(A) CD25 surface expression on Jurkat T-cells upon activation with PMA/Ionomycin and stimulation with TG (10 µM, 2 h, 4 h)  
(B) Histogram of CD25 surface expression of resting Jurkat T-cells cultured in TRP free medium and stimulated with TG [10 µM] for 2 h 
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2.2  Initiation of the integrated stress response in human Jurkat 
T-lymphocytes 
Having ascertained that in cell cultures supplemented with even low TRP free serum 
concentrations and exposure to TG did not induce overt apoptosis in Jurkat cells, the 
effects of TG on Jurkat T-cells were analyzed for its ability to induce stress response 
proteins to serve as a positive control.  
Jurkat cells (1*106) were cultured in TRP replete medium, supplemented with 1 % TRP free 
serum, and exposed to TG (1 µM, 10 µM) for up to 1h.  
Compared to untreated cells (0µM), exposure to 1µM and 10µM TG induced an up to 1,24 
and 1,61-fold increase in phosphorylated eIF2α, respectively (Fig. 51 and Fig. 52), peaking 
after 60 min of exposure. Induction of stress related proteins through exposure to TG was a 
rapid process, detectable within 15 minutes, which is in line with published data [159, 167, 174, 
196, 214, 258]. In contrast, constitutively expressed eIF2α was not affected by TG treatment 
and relatively steadily expressed, except for the 60 min timepoint, illustrated by an 
approximately 20 % decrease in eIF2α phosphorylation. 
 
15 min             30 min             60 min
M   0µM    1µM   10µM  0µM    1µM    10µM  0µM    1µM   10µM
peIF2α
eIF2α
55 kDaα‐Tubulin
55 kDaα‐Tubulin
 
Fig. 51: Effects of TG stimulation on Jurkat T-cells 
 
 
Phosphorylation of eIF2α in Jurkat T-cells upon TG treatment [1 µM, 10 µM] for different time points  
(15 min, 30 min, 60 min)  
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Fig. 52: Densitometric analysis of eIF2α phosphorylation 
in Jurkat cells upon challenge with TG (1 µM, 10 µM) for 
up to 60 min 
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Fig. 53: Densitometric analysis of constitutive eIF2α expression in 
Jurkat cells upon challenge with TG (1 µM, 10 µM) for up to 60 min 
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To investigate the cellular response of Jurkat cells to TRP deprivation, Jurkat T-cells 
(1*106) were activated with PMA/Ionomycin and either cultured in TRP deplete or TRP 
replete medium, both supplemented with 10 % TRP free serum, for 24 h. Thereafter, cells 
were challenged with TG (1µM, 10 µM) for up to 4 h.  
A decrease in eIF2α phosphorylation upon activation with PMA/Ionomycin was observed in 
cells maintained in TRP replete culture medium which resulted in an increase of the fold 
change between TRP deplete and TRP replete culture conditions (Fig. 54). Addressing the 
molecular background of this observation is beyond the scope of this thesis.  
In contrast to the findings with phosphorylation of eIF2α, the levels of CHOP expression 
remained constant upon activation in cells maintained in TRP replete medium, whereas 
CHOP expression was enhanced in cells cultured in TRP deplete medium and even further 
increased upon challenge with TG compatible with activating the GCN2 pathway.  
Cellular stress, indicated by increased levels of peIF2α expression, was additionally 
increased upon exposure to TG, as represented by a fold increase of 1,16 and 1,73 in 
resting and activated cells, respectively. However, no elevated levels of eIF2α 
phosphorylation were observed under TRP replete culture conditions. 
In contrast to peIF2α, CHOP expression levels were elevated in cells maintained in TRP 
deplete as well as TRP replete culture medium, as shown by a 2,18- and 3,37-fold 
induction in resting and in activated cells. Levels of CHOP expression were particularly 
enhanced in TRP deplete versus TRP replete medium indicated by a 4,22-fold increase in 
resting and a 9,04-fold increase in activated cells, respectively. Unphosphorylated eIF2α 
was stably expressed upon challenge with TG, whether cells were maintained in TRP 
deplete or TRP replete medium.  
Thus, Jurkat cells represented a model system, in which stress response proteins were 
inducible by exposing cells to TRP deplete culture conditions as well as to the ER stress 
inducing compound TG. 
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Fig. 54: Induction of the ISR in the Jurkat T-cell line 
(A) ISR marker protein expression; (B) Densitometric analysis of eIF2α phosphorylation; (C) Densitometric analysis of endogenous 
eIF2α expression; (D) Densitometric analysis of CHOP expression. Fold increase was calculated by dividing ratios of TRP deplete by 
TRP replete medium. 
 
 
 Without TG 
 Resting Activated 
 TRP deplete TRP replete TRP deplete TRP replete 
eIF2α 0,96 1,20 
peIF2α 1,22 1,50 
CHOP 1,60 2,94 
Table 8: Fold increase of ISR marker protein expression in Jurkat cells 
Fold increase was calculated by dividing the ratio values of TRP deplete by TRP replete conditions 
Numbers of peIF2α and eIF2α indicate mean values of 2 experiments (4 h timepoint). 
 
Overall these data suggest that the integrated stress response was clearly detectable in 
Jurkat T-cells upon TRP starvation, which was indicated by increased expression of two 
marker molecules, peIF2α and CHOP (Table 8).  
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2.3 Autophagy in Jurkat T-lymphocytes upon TRP deprivation 
In order to investigate the effects of TRP deprivation on the induction of autophagy, Jurkat 
T-cells (1*106) were activated with PMA/Ionomycin, cultured for 24 h in either TRP deplete 
or TRP replete medium, both supplemented with 10 % TRP free serum, and challenged 
with TG (1 µM, 1 h). 
The results show that, in contrast to ISR related proteins, autophagy was not induced in 
Jurkat cells, as depicted in Fig. 55 and Fig. 56. Beclin-1 expression was not enhanced in 
cells cultured under TRP starvation compared to cells cultured in TRP replete medium. 
Autophagy induction was as well monitored by the autophagosomal form of LC3. However, 
the antibody used did not work out for proper detection (data not shown).   
These data indicate that autophagy is not induced during the cellular response to TRP 
deprivation but rather that Jurkat T-cells sensing TRP deficiency respond by a specific 
induction of the ISR.  
 
TRP deplete TRP replete
M      R        P/I        R         P/I
Beclin‐1
70 kDa
35kDa
GAPDH
     
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1,8
2
Resting PMA/Ionomycin
R
at
io
 B
ec
lin
-1
/G
A
P
D
H
Beclin-1 expression in Jurkat T-cells upon activation with 
PMA/Ionomycin
TRP deplete
TRP replete
 
Fig. 55: Autophagy induction in Jurkat T-cells 
(A) Autophagy induction monitored via Beclin-1 protein expression and (B) respective densitometric analysis 
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Fig. 56: Autophagy induction in human Jurkat T-cells 
(A) Beclin-1 protein expression in Jurkat cells upon TRP deprivation and (B) respective densitometric analysis 
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3 The Integrated Stress Response and alternative pathways 
for the adaption to nutrient deprivation in primary human 
T-lymphocytes 
3.1.1 Apoptotic response of primary human T-lymphocytes to TG treatment 
To define optimal concentrations for TG exposure on primary human T-cells, susceptibility 
of apoptosis was determined by Annexin V / DAPI staining. Therefore human primary 
T-lymphocytes (2*106) were activated with PMA/Ionomycin and cultured in either TRP 
deplete or TRP replete medium and stimulated with TG (1 µM, 10 µM) for 1 h.  
As Fig. 57 shows, an increase in apoptotic response was observed when cells were 
stimulated with TG concentrations higher than 1 µM. Thus in contrast to Jurkat T-cells, 
primary human T-lymphocytes do not tolerate TG doses greater than 1 µM.  
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Fig. 57: Apoptosis rate of human T-cells upon TG stimulation 
Annexin V / DAPI staining of flow cytometric measurement (A) Resting primary human T-cells cultured in TRP deplete medium             
(B) Resting primary human T-cells cultured in TRP deplete medium and stimulated with TG [1 µM] (C) Resting primary human T-cells 
cultured in TRP deplete medium and stimulated with TG [10 µM] 
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3.2 Effects of TRP deprivation on the proliferative response of primary 
human T-lymphocytes 
To characterize functional effects of TRP deprivation on primary human T-cells, CD25 cell 
surface expression, proliferation, absolute cell number and apoptotic decline were 
determined in parallel. For this purpose, human primary T-lymphocytes (1*105) were 
activated with αCD3/CD28 and cultured in either TRP deplete or TRP replete medium for 
up to 7 days. 10 % TRP free serum was determined to represent optimal serum 
concentration for medium supplementation. This concentration was used throughout the 
experimental investigations in primary human T-cells.   
Cells cultured in TRP deplete as well as TRP replete medium showed similar levels of 
expressed CD25 on their surface, induced by αCD3/CD28 stimulation, indicating cellular 
activation (Fig. 58). The level of CD25 expression slightly decreases over time in cells 
cultured under TRP starvation. 
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Fig. 58: CD25 cell surface expression of primary human T-cells upon activation with αCD3/CD28 
CD25 expression on primary human T-cells after activation on day 7: Resting (grey filled line), activated T-cells cultured in TRP deplete 
medium (red line) and activated T-cells cultured in TRP replete medium (blue line) 
 
 
 
day 7 
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The proliferative response of T-cells stimulated in TRP deplete and TRP replete cell culture 
medium was assessed by CFSE dilution and the division index as given by the FlowJo 
program.  The percent CFSE negative cells depicts the total proportion of cells that have 
undergone cell division by dilution of the dye. The division index depicts the average 
number of cell divisions the responding cell population underwent, meaning it ignores the 
peak of undivided cells and has a particular focus on the performance of the cells, which 
are dividing. Our results show that primary human T-lymphocytes, activated with 
αCD3/CD28 and cultured under TRP replete conditions, showed abundant proliferation, 
indicated by 90 % CFSE negative cells (Fig. 59). In contrast, cells cultured in TRP deplete 
conditions showed a significantly impaired proliferative response to αCD3/CD28 
stimulation. This was indicated by a 50 % reduction of CFSE negative cells. Likewise, the 
division index was reduced by 60% in cells stimulated in TRP deplete conditions, which is 
compatible with an inability of cells responding to αCD3/CD28 stimulation to undergo 
further cell divisions. These observations suggest that a small proportion of cells is able to 
divide, but 60 % of the total cell population is arrested in cell cycle, as claimed by Munn et 
al. in 1999. [118]    
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Fig. 59: Proliferative capacity of human primary T-cells 
CFSE dilution and division index in TRP deplete and TRP replete medium supplemented with 10 % TRP free serum on day 7: 
 (A) Unstained Control; (B) Activated primary human T-cells cultured in TRP deplete medium; (C) Activated primary human T-cells 
cultured in TRP replete medium 
 
  Division Index 
  day 2 day 3 day 5 day 7 
TRP deplete 0,04 0,21 0,31 0,50 Activated 
TRP replete 0,07 0,45 1,18 1,18 
Table 9: Division index of primary human T-cells activated with αCD3/CD28 
 
 
These data are consistent with previous published literature [118] which shows that primary 
human T-lymphocytes cultured under TRP starvation were not inhibited to be activated by 
αCD3/CD28, but were markedly impaired to proliferate.   
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The effect of TRP depletion became even clearer when absolute cell numbers were 
analyzed. The absolute count of T-cells cultured in TRP deplete conditions remained at the 
same level, represented by 1*105 cells, even after 7 days of activation with αCD3/CD28, 
whereas cells cultured in TRP replete culture conditions were able to expand in total cell 
number of up to three fold, represented by 3,2*105 cells (Fig. 60). No differences in 
absolute cell numbers were denoted in resting T-cells cultured in TRP deplete or TRP 
replete medium.   
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Fig. 60: Expansion of primary human T-cells
Absolute cell number of primary human T-cells cultured in either TRP deplete or TRP replete medium 
 
 D – RESULTS 
- 82 - 
Since CFSE dilution showed 40 % of proliferating cells in TRP deplete medium but in 
parallel absolute cell count remained constant, we speculated whether altered apoptosis 
would explain this paradox finding. Indeed, as depicted in Fig. 61, cells cultured in TRP 
deplete medium are more susceptible to undergo apoptotic cell death (50 % Annexin V 
positive cells by day 5) as compared to TRP replete conditions (12 % Annexin V positive 
cells by day 5). 
Thus, the increased apoptotic response of T-lymphocytes cultured under tryptophan 
starvation may represent the correlation between proliferation (Fig. 59) and constant cell 
number (Fig. 60).  
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Fig. 61: Apoptotic susceptibility of human primary T-cells 
Annexin V / DAPI staining of primary human T-cells (A) Unstained Control; (B) Activated human primary T-cells cultured in TRP deplete 
medium; (C) Activated human primary T-cells cultured in TRP replete medium 
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3.3  Induction of the ISR in primary human T-lymphocytes 
Optimal cell numbers were determined to range between 6*106 and 8*106, to detect ISR 
responsive proteins by western blot. In our effort to reproduce published data by Munn et 
al., first, primary human T-cells (7*106) were activated with PMA/Ionomycin and cultured in 
either TRP deplete or TRP replete medium for 24 h.  
The CHOP transfected lysate shows a positive signal in donor 2, though no CHOP 
expression was observed in primary human T-cells, which means that CHOP was not 
expressed in primary human T-cells (Fig. 62). 
As Fig. 63 illustrates, no increase in eIF2α phosphorylation was denoted in resting or 
activated cells cultured in TRP deplete medium, which was represented by a fold change of 
1,07 and 1,04 (Table 10). Additionally, activation with PMA/Ionomycin did not lead to an 
increased phosphorylation of eIF2α, shown by a fold change of only 0,94 and 0,95.  
These results indicated that primary human T-lymphocytes did not respond to TRP 
deprivation by the initiation of an integrated stress response neither in resting conditions 
nor upon activation with PMA/Ionomycin.  
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Fig. 62: Induction of ISR in human primary T-cells
CHOP expression upon activation with PMA/Ionomycin 
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Fig. 63: Initiation of the ISR in human primary T-cells
Phosphorylation status and endogenous expression of eIFα upon activation with PMA/Ionomycin. Numbers depict fold changes. Fold 
changes were calculated by dividing TRP deplete by TRP replete or activated by resting ratios.  
 
 
  Fold Change 
  TRP deplete TRP replete 
Resting 1,07 peIF2α 
Activated 1,04 
 
  Fold Change 
  Activated Resting 
TRP deplete  0,99 peIF2α 
TRP replete  1,00 
Table 10: Fold increase of stress response marker proteins 
Numbers indicate the mean of the fold increase of 2 experiments 
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We found that cellular stimulation with αCD3/CD28, compared to PMA/Ionomycin, induced 
more pronounced activation, indicated by the induction of the cell surface marker CD25. 
Therefore, as next step, human primary T-lymphocytes (6*106) were activated with 
αCD3/CD28 and cultured in either TRP deplete or TRP replete medium for up to 7 days.  
In addition, cells were also challenged with TG (1 µM) for 1h, in order to increase 
intracellular stress. 
Remarkably we found that activation with αCD3/CD28, in contrast to PMA/Ionomycin in 
murine splenocytes, induced higher phosphorylation of eIF2α and increased expression of 
CHOP (Fig. 64) in activated as compared to resting cells, irrespective of whether the cells 
were cultured in TRP deplete or TRP replete medium.  
Of note, no elevated levels of peIF2α or CHOP were observed in cells cultured in TRP 
deplete or TRP replete medium, whether or not the cells were resting or activated, 
indicating that in fresh human T-cells the ISR is not inducible by tryptophan starvation. 
The ER stress inducer TG was shown to enhance expression levels of peIF2α and CHOP 
in resting cells maintained in TRP deplete conditions on day 2, but had only a marginal 
effect whether or not cells were activated (Table 11).  
These data are in contrast to results obtained from Jurkat T-cells, which show that upon 
TG challenge, increased phosphorylation of eIF2α is solely present by culturing cells in 
TRP replete medium. Furthermore the data partially coincide with results obtained from 
murine cells. No increased eIF2α phosphorylation was observed in mouse splenocytes in 
TRP deplete cell culture conditions. 
Overall, the induction of stress related proteins in primary human T-lymphocytes is rather 
dependent on the type of activation stimulus than on withdrawal of TRP from the 
environment.  
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Fig. 64: Phosphorylation and endogenous expression of eIF2α and CHOP in αCD3/CD28 activated primary human T-cells
The fold increase was calculated by dividing TRP deplete by TRP replete or activated by resting ratios 
 
  Fold Increase by TG 
  TRP deplete TRP replete 
Resting 0,96 1,00 
eIF2α 
Activated 1,04 1,09 
Resting 1,53 0,96 peIF2α 
Activated 1,14 1,13 
Resting 1,20 0,95 CHOP 
Activated 0,90 1,00 
Table 11: Effects of TG stimulation on αCD3/CD28 activated primary human T-cells
The fold increase was calculated by dividing +TG by -TG ratios 
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Because no induction of the ISR was observed in cells harvested after 2 days of TRP 
starvation, we speculated that in order to detect ISR induction, primary human T-cells need 
to be exhausted from intracellular tryptophan stores. Therefore, human primary 
T-cells (6*106) were activated with αCD3/CD28 on day 0 and cultured in either TRP deplete 
or TRP replete medium, both supplemented with 10 % TRP free serum, for up to 7 days. 
In order to increase intracellular stress, cells were additionally exposed to TG (1 µM) for 
1 h. 
Activation with αCD3/CD28 induced increased peIF2α and endogenously expressed eIF2α 
and CHOP on d2 to a similar extent in cells either cultured in TRP deplete and TRP replete 
medium (Table 12). Increased expression of endogenous eIF2α and CHOP was retained 
for up to 7 days post activation. However, as shown before, whole protein levels are 
increased in the primary phase of activation through stimulation with αCD3/CD28, which 
suggests that activation slightly increases total protein expression, which is not ISR 
specific.  
Remarkably, no increased eIF2α phosphorylation or CHOP expression was observed even 
after 7 days of culture in cells maintained in TRP deplete medium versus TRP replete 
culture medium. 
However, a slight enhancement, represented by a 1,3-fold increase, in peIF2α and CHOP 
was denoted at day 5 post activation, indicating that enforced cellular stress (prolonged 
activation, TG exposure and TRP exhaustion) may elicit the induction of the ISR (Fig. 67 
and Table 12).  
 D – RESULTS 
- 88 - 
 
Endogenous expressed control 
proteins 
ISR induced stress proteins 
R         A       R         A       R        A       R        A          
0µM             1µM             0µM            1µM
TRP deplete TRP replete
GAPDH
35kDa
GAPDH
35kDa
GAPDH
35kDa
GAPDH
35kDa
d2
d3
d5
d7  
R         A       R       A       R        A      R         A          
0µM            1µM              0µM            1µM
TRP deplete TRP replete
d2
d3
d5
d7
peIF2α
35kDa
peIF2α
35kDa
peIF2α
35kDa
peIF2α
35kDa  
eIF2α
35kDa
d2
d3 
d5 
d7 
35kDa
35kDa
35kDa
eIF2α
eIF2α
eIF2α
R         A       R       A       R        A      R         A          
0µM            1µM              0µM            1µM
TRP deplete TRP replete
 
d2
d3
d5
d7
R         A       R        A       R        A      R          A          
0µM            1µM              0µM            1µM
TRP deplete TRP replete
25kDaCHOP
25kDa
25kDa
25kDa
CHOP
CHOP
CHOP  
Fig. 65: ISR marker protein expression upon activation with αCD3/CD28 and exposure to TG [1 µM, 1 h] 
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Fig. 66: Densitometric measurement of ISR marker protein expression after stimulation with αCD3/CD28 and TG [1 µM, 1 h] 
 
 
 
   -TG +TG 
   d2 d3 d5 d7 d2 d3 d5 d7 
trp 
depleteResting 
trp 
replete 
1,01 1,02 0,85 1,01 0,97 1,04 0,93 0,87 
trp 
deplete
eIF2α 
Activated 
trp 
replete 
0,86 0,89 0,78 0,87 0,81 0,80 0,96 0,72 
trp 
depleteResting 
trp 
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0,67 1,00 0,80 0,94 1,08 0,96 1,07 0,82 
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peIF2α 
Activated 
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0,85 0,94 0,83 1,01 0,86 0,84 1,34 0,90 
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0,91 0,72 0,70 0,93 1,13 1,13 1,22 1,18 
trp 
deplete
CHOP 
Activated 
trp 
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1,05 0,97 0,89 0,87 0,95 0,99 1,30 0,76 
Table 12: Fold changes in phosphorylation and endogenous expression of eIF2α and CHOP in human 
primary T-cells over 7 days 
Fold changes were calculated by dividing TRP deplete by TRP replete ratios 
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Fig. 67: Expression of stress related proteins in primary human T-cells on day 5 of maintenance in TRP deplete or TRP replete 
culture medium with additional TG exposure
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In parallel to investigating the ISR on protein level, the RNA expression profile during ISR 
induction was monitored. 
mRNA expression of ISR specific genes was shown to be apparently different compared to 
protein expression of ISR responsive molecules. Activation through αCD3/CD28 did not 
increase the expression level of CHOP or ATF4 in contrast to observations made on 
translational level.  
TG is able to increase CHOP and ATF4 mRNA levels in resting human T-cells in the initial 
phase of activation, represented by day 2 and day 3. Overall, resting cells cultured in TRP 
deplete conditions show slightly higher expression in stress responsive genes compared to 
cells cultured in TRP replete medium, whereas similar levels of mRNA expression was 
observed in activated cell cultures.  
mRNA levels of constitutively expressed eIF2α were comparable in resting cells cultured in 
TRP deplete and TRP replete as well as in activated cells, cultured either in TRP deplete or 
replete conditions. In contrast to CHOP and ATF4 mRNA, challenge with TG does not 
change expression levels of eIF2α, neither in resting nor in activated cells.  
These observations suggest that the induction of the ISR upon tryptophan deprivation is 
initiated on transcriptional, but not on translational level in primary human T-lymphocytes. 
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Fig. 68: mRNA expression of primary human T-cells after activation with αCD3/CD28 and stimulation with TG (1µM) for 1h over 
7 days 
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3.4 Alternative pathways for the adaption to nutrient deprivation in 
primary human T-lymphocytes 
3.4.1  Induction of autophagy in primary human T-lymphocytes 
Since autophagy is also regulated in the cellular adaption to stress, the next step was to 
investigate the involvement of autophagy upon tryptophan starvation in primary human 
T-cells. For this reason, human primary T-lymphocytes (6*106, 7*106) were activated with 
PMA/Ionomycin or αCD3/CD28 and either cultured in TRP deplete or TRP replete medium, 
both supplemented with 10 % TRP free serum. 
Autophagy induction was monitored by the expression of the autophagy specific protein 
Beclin-1. As shown in Fig. 69, Beclin-1 expression is not increased in cells cultured in TRP 
deplete medium.   
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Fig. 69: Autophagy induction in primary human T-cell
7*106 human primary T-lymphocytes stimulated with PMA/Ionomycin and cultured in TRP deplete or TRP replete medium for 24 h  
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To ascertain that intracellular TRP storages were fully emptied, human primary 
T-lymphocytes were activated through stimulation with αCD3/CD28 on d0 and maintained 
in culture for up to 7 days. Additionally, for increasing cellular stress, TG (1 µM) was added 
for 1 h before the analysis of autophagy responsive proteins.  
As outlined in Fig. 70, no enhanced Beclin-1 expression was observed when cells were 
starved of TRP, even in the presence of TG. However, as for the expression of stress 
related proteins, activation with αCD3/CD28 slightly enhances Beclin-1 expression levels, 
retaining for up to 7 days.   
Summarizing, these results indicate that autophagy is not initiated in human primary 
T-lymphocytes upon TRP starvation.  
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Fig. 70: Beclin-1 expression in primary human T-cells upon activation on day 
6*106 human primary T-lymphocytes were activated with αCD3/CD28, cultured in TRP deplete or TRP replete medium for 8 days and 
exposed to TG [1 µM, 1 h] 
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3.4.2 Initiation of the mTOR pathway in primary human T-lymphocytes 
Another key downstream signaling pathway, mTOR, was investigated in the context of TRP 
deprivation. Differently from ISR and autophagy induction, phosphorylation of mTOR and 
its downstream signaling molecule rpS6K decreases upon cellular stress.  
Thus, in parallel to examining the ISR and autophagy, the involvement of mTOR in 
response to TRP withdrawal was investigated. 
Therefore, human primary T-lymphocytes (6*106) were activated with αCD3/CD28 
stimulation and cultured in TRP deplete or TRP replete medium, supplemented with 10 % 
TRP free serum, for up to 7 days. In order to increase intracellular stress, cells were 
additionally stimulated with TG (1 µM) for 1 h.   
As Fig. 71 shows, cellular activation by αCD3/CD28 resulted in an increase of mTOR and 
rpS6K phosphorylation as well as endogenous mTOR expression during the initial phase, 
which was in line with ISR responsive proteins. This increase is retained for 7 days peaking 
at a maximum on day 5. 
Phosphorylation of mTOR was slightly decreased in cells cultured in TRP deplete medium 
compared to TRP replete medium during the initial stress phase (day 2 and day 3), 
indicating that the mTOR pathway was affected upon TRP deprivation in primary human 
T-cells.  
The role of the mTOR pathway upon TRP starvation became even more evident, when the 
phosphorylation status of the mTOR downstream molecule rpS6K was assessed. 
Phosphorylation of rpS6K decreased in resting cells maintained in TRP free cell cultures 
compared to cells cultured in TRP replete medium peaking at day 7, represented by an up 
to 72 % reduction in rpS6K phosphorylation (Fig. 72 and Table 13). The additional 
challenge with TG resulted in a significant increase in rpS6K phosphorylation in resting 
cells, but did not additionally affect phosphorylation levels in activated cells.  
Remarkably, phosphorylation levels of rpS6K were markedly decreased at day 7 after 
stimulation with αCD3/CD28. Challenge with TG abrogates the effect observed between 
cells cultured in TRP deplete versus TRP replete conditions.   
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Overall these data indicate that the mTOR pathway is involved in the cellular response to 
TRP deprivation of human primary T-lymphocytes, which is shown by decreased 
phosphorylation of mTOR and its downstream marker rpS6K.  
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Fig. 71: Initiation of the mTOR pathway in human primary T-cells upon TRP deprivation 
Endogenous expression and phosphorylation status of mTOR and rpS6K upon activation with αCD3/CD28 and TG stimulation (1 µM, 
1 h). Fold changes were calculated by dividing activated by resting values 
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Fig. 72: Fold changes in rpS6K phosphorylation on day 7 after activation with αCD3/CD28
Fold decrease was calculated by dividing TRP replete by TRP deplete conditions 
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   -TG +TG 
   d2 d3 d5 d7 d2 d3 d5 d7 
TRP 
replete Resting 
TRP 
deplete 
0,78 0,82 0,95 0,84 1,36 0,95 1,13 0,97 
TRP 
replete 
pmTOR 
Activated 
TRP 
deplete 
0,87 0,83 1,07 0,99 1,20 0,92 1,22 1,13 
TRP 
replete Resting 
TRP 
deplete 
0,91 0,84 0,81 0,28 1,05 1,02 0,66 0,49 
TRP 
replete 
rpS6K 
Activated 
TRP 
deplete 
0,94 0,93 0,96 2,43 1,02 1,05 1,18 1,52 
Table 13: Fold decrease of phosphorylated mTOR pathway marker proteins
Numbers indicate the fold decrease. The fold decrease was calculated by dividing TRP replete by TRP deplete ratios.  
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3.5 Summary 
In the course of this project, following observations were made: 
 
o Murine system 
 Activation with PMA/Ionomycin induced increased expression of stress 
related proteins in cells maintained in TRP deplete and TRP replete medium 
 ISR was not induced in cells starved of TRP 
 No induction of autophagy upon TRP deprivation was observed in murine 
cells 
 
These observations made in the murine system suggest that the expression of stress 
related proteins in murine cells is dependent on cellular activation and stand in contrast 
to published results by Munn et al.  
   
o Jurkat T-cells 
 Activation with PMA/Ionomycin showed no effect on the expression of stress 
related proteins in TRP deplete and TRP replete medium 
 Challenge with thapsigargin increased the expression of stress related 
proteins in cells cultured in TRP replete, but not in TRP deplete medium 
 ISR induction was observed in cells cultured under TRP starvation 
 No induction of autophagy was detected upon TRP starvation 
 
These data propose that Jurkat cells, do not respond to activation stimuli, in contrast to 
murine and primary human cells. This may be related to the anyhow constant activation 
of this cell line. However, Jurkat cells induce the ISR program upon tryptophan 
deprivation, while autophagy is not affected during cellular adaption upon tryptophan 
withdrawal.   
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o Primary human T-cells 
 Activation with αCD3/CD28 induced CD25 cell surface marker expression 
similarly in TRP deplete and TRP replete conditions 
 TRP starvation inhibited cellular proliferation and increased the susceptibility 
to apoptosis 
 Activation with PMA/Ionomycin did not lead to the increased expression of 
stress related proteins 
 Activation with αCD3/CD28, in contrast to PMA/Ionomycin, enhanced the 
expression of stress related proteins. However, the extent of increase of 
stress related proteins was similar in TRP deplete and TRP replete cell 
culture conditions 
 Stimulation with TG caused an upregulation of stress related proteins in cells 
cultured in TRP deplete and TRP replete conditions, which stays in contrast 
to observations made in Jurkat cells 
 Upon TRP starvation no ISR induction was observed on protein level 
 However, stress related genes were upregulated on transcriptional level 
 Autophagy was no involved in the cellular adaption to TRP deprivation 
 The involvement of the mTOR pathway was noted upon TRP starvation at 
later timepoints, suggesting that internal TRP storages had to be used up 
before cellular adaption could be initiated 
 
These findings suggest that the type of activation stimulus plays a role in primary 
human T-cells with respect to ISR marker protein expression, which is also observed in 
different expression of CD25 cell surface marker (data not shown). Stimulation with 
αCD3/CD28 represents a T-cell receptor mediated activation stimulus, whereas 
stimulation with PMA/Ionomycin is achieved through non physiological activation of the 
protein kinase C, which could probably affect the outcome in these cells. Moreover, the 
ISR and autophagy is not responsible for the inhibition of allogeneic T-cell proliferation. 
However, the PI3K/mTOR pathway may play a role in the cellular response to 
tryptophan deprivation in human primary T-cells upon depletion of intracellular 
tryptophan storages thus accounting for the inhibition of proliferation.  
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E - DISCUSSION AND CONCLUSION 
IDO, an intracellular enzyme is the rate limiting enzyme of tryptophan metabolism in human 
organisms and is able to deplete tryptophan from the local microenvironment and 
accumulate tryptophan metabolites. Both these effects have been suggested to be involved 
in immunoregulation and contribute to the induction of immune tolerance. [110] Tryptophan is 
one of nine essential amino acids which can neither be stored nor synthesized de novo by 
the body and thereby has to be supplemented by diet. The perception of IDO mediating 
fundamental immunoregulation was initiated when in 1998 the group around Munn et al. 
[116] claimed that IDO is able to exert profound immunosuppressive effects in mammalian 
cells, especially in semi-allogeneic pregnancy in mice.  
Several working mechanisms were suggested for the action of tolerance induction by IDO. 
The tryptophan starvation theory states that tryptophan deprivation in the cellular 
microenvironment leads to the inhibition of T-cell proliferation, which was also proposed as 
the cause for the observations made by Munn in 1998 [116]. Furthermore, it was 
demonstrated that primary human T-cells, cultured within a milieu devoid of the essential 
amino acid tryptophan, were not able to proliferate, compared to cells cultured under 
tryptophan abundant conditions. This inhibition could be reversed by the addition of 
tryptophan. [118] Proliferative inhibition upon tryptophan starvation was also observed in 
human peripheral blood mononuclear cells. Moreover it was found that the proliferative 
inhibition was related to missing tryptophan and not to an inhibitory effect of tryptophan 
metabolites. [134]  
Another working model suggested for the tolerogenic effect exerted by IDO, was the 
accumulation of tryptophan metabolites, so called kynurenines in the cellular 
microenvironment. Kynurenines, especially 3-hydroxykynurenine and 3-hydroxyanthranilic 
acid were suggested to trigger apoptosis thus leading to a suppression of allogeneic T-cell 
proliferation. [124, 126, 127]  
The proliferative decline of murine T-cells and the subsequent recovery by the addition of 
tryptophan in the course of cellular response to tryptophan deprivation was explained by a 
stable cell cycle arrest for at least 12 h by colleagues of Lee et al. They suggested that the 
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inability to proliferate is not due to an inability of synthesizing proteins but rather to an 
arrest at a specific cell cycle checkpoint. [119]   
However Fallarino et al. observed in 2006 that both, tryptophan deprivation and kynurenine 
accumulation in the local environment are necessary for tolerance induction. [261]    
In contrast to these findings, Frumento et al. claimed in 2002 that the slight decrease in 
proliferation could not be traced back to deprived tryptophan in the culture medium but 
rather to unknown factors missing in the tryptophan free serum, which seem to be vitally 
important for cellular expansion. [124] To this point, the possibly absent unknown factors 
normally contained in the serum, could be excluded as a source of influencing cellular 
proliferation, since cells grown in standard medium supplemented with the same 
tryptophan free serum, showed no decline in proliferation in our model system. 
 
If a cell is lacking an essential amino acid, several cellular adaption processes can be 
initiated to overcome this stress situation. In 2005, Munn et al. suggested a novel 
mechanism of T-cell regulation by tryptophan starvation. He reported that mouse 
splenocytes and splenic T-cells are capable of initiating the integrated stress response 
(ISR), upon sensing tryptophan deprivation via the GCN2 pathway. [4] The ISR leads to the 
inhibition of global protein translation on the one hand and to the expression and 
phosphorylation of stress related proteins, i.e. eIF2α and CHOP, on the other hand. The 
involvement of the ISR has since then only been scarcely addressed in human cells. 
Alternative cellular pathways also suggested to be initiated upon the cellular response to 
nutrient deprivation include autophagy and the PI3K/mTOR pathway.   
To uncover whether any type of cellular stress response represents a molecular 
mechanisms of proliferative inhibition by tryptophan starvation in primary human T-cells, 
we analyzed marker molecules of the ISR, autophagy and the PI3K/mTOR pathway in 
resting and activated human T-cells upon culture in tryptophan free medium. 
 
First, we ensured that primary human T-cells activated by αCD3/CD28 and maintained in 
TRP free medium were inhibited in proliferation. We made the observations that T-cells 
showed inhibited proliferation while maintaining stable cell numbers, corroborating that 
tryptophan deprivation prevents T-cells from a full response to polyclonal stimulation. 
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Furthermore, our observations showed an increased apoptotic response in αCD3/CD28 
activated primary human T-lymphocytes upon maintenance in tryptophan deplete culture 
conditions, which is in line with previous published data. [119]  
These data suggest that the proliferative inhibition may be related to increased apoptotic 
susceptibility of T-cells under tryptophan starvation.  
 
For analysis of the ISR we first investigated phosphorylation of the key molecule eIF2α, at 
which diverse stress related pathways converge. Some groups revealed that 
phosphorylation of the α-subunit of the eukaryotic initiation factor 2 was increased upon 
withdrawal of the essential amino acid leucine in mouse and hamster cells. [162, 174, 262].  
In 2010, Zaborske et al. stated that even in lower eukaryotes, for instance yeast, the 
phosphorylation of the eukaryotic initiation factor 2α is detected upon tryptophan 
withdrawal. [263] 
In our study, we observed that ISR responsive marker proteins were expressed in Jurkat 
T-cells upon tryptophan starvation, indicating that the ISR was detectable in response to 
tryptophan deprivation in our model system. We found a 1,34-fold increase of peIF2α and a 
2,94-fold increase of CHOP by 4 hours of culture of Jurkat cells in TRP free medium.  
However, in human primary T-cells stress related proteins were only somewhat enhanced 
upon cellular activation with αCD3/CD28, in contrast to activation with PMA/Ionomycin, but 
no difference was observed whether or not cells were maintained in TRP deplete or TRP 
replete cell culture medium. Cellular activation appeared to generally enhance protein 
translation since the cellular content of unphosphorylated eIF2 was as well increased. 
These data indicate that the ISR is not involved in the cellular adaption of human primary 
T-cells to tryptophan deprivation in their environment. 
 
As second marker, the expression of the downstream molecule CHOP was as well 
examined for the induction of the ISR. Munn et al. showed the induction of the GCN2 
pathway indirectly via CHOP expression in PMA/Ionomycin activated murine splenocytes 
and splenic T-cells deprived of tryptophan. [4] Other publications claim that CHOP protein 
and mRNA expression is enhanced in various types of mouse and hamster cells, if either 
depleted of glucose or another essential amino acid, leucine. [162, 183, 196, 264] In 2009, 
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Barnes et al. postulated that they were able to detect CHOP mRNA after depriving human 
monocytes from tryptophan. [265]  
Like with peIF2α and different from observations by Munn et al. in 2005, no CHOP signal 
was noted by western blotting in murine cells. While we cannot finally exclude that 
discrepancies in technical procedures were the cause for this difference, our findings in 
Jurkat cells demonstrating a significant effect of tryptophan starvation on CHOP 
expression, validated our approach in human cells.   
As well, we detected CHOP protein expression in human T-lymphocytes upon activation 
with αCD3/CD28. However, no increased CHOP expression was observed in cells cultured 
in tryptophan deplete compared to tryptophan replete conditions. 
Forouzandeh et al. described in 2008 that CHOP expression is induced in αCD3/CD28 
activated human primary CD8+ T-cells upon culturing the cells in either tryptophan free 
medium or upon co-culture with IDO expressing fibroblasts. Furthermore, CHOP 
expression was also increased upon addition of tryptophan metabolites. Unfortunately, the 
group did not include a negative control of human T-cells alone cultured under tryptophan 
replete conditions, which implies that they cannot exclude any interferences of the 
fibroblast co-culture with the cellular reaction of these T-cells. [3] With respect to our work 
this means that CHOP is expressed upon activation, which is in line with published data by 
Forouzandeh. However, our observations showed that CHOP was as well expressed in 
cells cultured in tryptophan replete conditions. Furthermore, it was observed that HeLa 
cells deprived from leucine, showed a 10-20 fold increase in CHOP mRNA expression. The 
latest timepoint of analysis in this study was 8 h after starvation induction. [219] 
Nevertheless, our experimental setup aimed for depleting intracellular tryptophan storages. 
Therefore later timepoints were examined for a differential mRNA expression. The fold 
increase of mRNA expression in our primary T-cells ranged between 0,2 and 3-fold which 
could be explained by lower total protein expression in primary cells compared to 
immortalized cell lines. 
 
Since no differences in ISR marker genes were observed under tryptophan deprivation, we 
added the chemical ER stress inducer TG to our cultures in order to increase the cellular 
stress in primary human T-cells. Thapsigargin is an enzyme isolated from the plant 
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Thapsia garganica and acts as a competitive calcium pump inhibitor in the ER, thereby 
depleting the ER from calcium while increasing cytosolic calcium concentrations.   
The treatment with TG slightly enhanced the expression of ISR marker proteins in primary 
human T-cells, which is in line with published data in mouse cells. [159, 167, 174, 196, 214, 258] In 
contrast to primary human T-cells, thapsigargin increases the expression of stress related 
proteins only in Jurkat cells cultured under tryptophan abundant conditions.  
Taken together, these observations suggest that human primary T-cells are very robust to 
initiate the ISR evoked by nutrient deprivation. Even additional chemical stress signals 
induce only a slight increase in the expression of stress related proteins. T-cells seem to 
avoid to initiate an integrated stress program, but rather to undergo apoptosis, if stress 
persists. In contrast, the Jurkat T-cell line appears to respond to “non-physiological” 
thapsigargin treatments and show higher resistance to apoptosis to even higher stimulatory 
concentrations. To conclude, these findings clearly indicate that in contrast to the common 
view, the GCN2 pathway is not a predominant mechanism of tryptophan deprivation in 
primary human T-cells.  
 
As several pathways interplay during the cellular adaption to amino acid deprivation, 
alternative nutrient sensing pathways were investigated in the course of cellular response 
to amino acid withdrawal.  
We were able to show that the alternative pathway, as the induction of autophagy, is not 
involved during cellular adaption to nutrient deprivation, especially during tryptophan 
starvation. Indeed, the expression level of the marker protein Beclin-1 remained 
unchanged whether or not cells were cultured in TRP deplete or replete conditions. These 
observations are in line with published data showing that autophagy is not induced, even 
upon total amino acid starvation, in a human colorectal cancer and HeLa cell line. [266, 267]   
 
Finally, our findings suggest that the mTOR pathway is indeed affected in primary human 
T-lymphocytes upon tryptophan starvation. In general, phosphorylation of mTOR marker 
proteins is decreased upon cellular stress, in contrast to the ISR and autophagy. Indeed, 
phosphorylation of mTOR and the downstream molecule rpS6K decreased in cells 
maintained in TRP deplete conditions by day 7 after polycloncal activation. We speculate 
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that this delayed effect is compatible with the presence of intracellular TRP stores, which 
have to be exhausted before stress responses are initiated. These observations are in line 
with published data stating that the GCN2 pathway is not sufficient for sensing amino acid 
deprivation in mammalian cells, but rather the mTOR pathway coincides, leading to a 
functional combined activity of the GCN2 and the mTOR pathway in the murine system. 
[178] 
Interestingly, in other cell systems, such as murine hepatocytes, the mTOR pathway was 
not involved in amino acid deprivation induced autophagy, which suggests that the effects 
of amino acid removal is more a coincidental phenomenon rather than a causal reason for 
the initiation of mTOR and autophagy in murine cells. [268].  
Previously published data indicated that single amino acid starvation, inter alia tryptophan 
withdrawal, does neither intervene with the induction of the integrated stress response nor 
with the activation of the mTOR pathway in human hepatoma cells. Only if these cells 
undergo total amino acid deprivation, phosphorylation of the downstream molecule 4E-BP1 
is decreased, leading to the inhibition of the mTOR pathway. [269, 270] With regards to our 
observations these data suggest that single amino acid deprivation is sufficient in primary 
human T-cells to induce the PI3K/mTOR pathway if intracellular tryptophan storages are 
entirely depleted of tryptophan.  
 
As previously described in literature, indoleamine-2,3-dioxygenase is expressed and 
functional active, meaning able to catabolize tryptophan, in murine granulocytes. [271] As 
recently demonstrated by our group, IDO is expressed in murine dendritic cells, but the 
enzyme is not catalytically active in this system (unpublished data). Moreover, our group 
also evidenced that human DCs, stimulated via IFN-γ and LPS, are able to produce 
functional IDO. [272]  
Even though similarities in the secondary structure of IDO in the murine and the human 
system can be observed, murine IDO (mIDO) has a threefold higher substrate efficiency 
ratio than human IDO (hIDO). [273]  The authors claim that the reason for this increased 
substrate efficiency could be explained by an increased level of tryptophan in the serum, 
requiring a higher tryptophan conversion rate.  
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The similarities and discrepancies between human and mouse IDO show that although the 
secondary structure is similar in both systems, the activity could be entirely different. The 
same could hold true for the stress sensor general control-nonderepressible 2. Even 
though the structural homology of GCN2 between yeast, mouse and human is similar, the 
functional activity could differ strongly.  
This study clearly found that murine cells, human cell lines and primary human cells react 
totally different upon diverse stress situations. One explanation for this disparity may be the 
fact that cell lines acquired several mutations. As our data show, Jurkat cells are less prone 
to apoptotic cell death compared to primary human T-lymphocytes which as well may result 
from genetic aberrations. Furthermore, Jurkat T-cells are in a state of constant activation 
rendering them unable to react to activation signals, in contrast to murine or primary human 
cells. Overall, these observations are compatible with a concept that human cell lines and 
fresh human cells use different strategies to overcome stress situations. Upon sensing 
amino acid starvation, cell lines as being immortalized, are inclined to initiate a stress 
related program, while fresh human T cells display a higher sensitivity to undergo 
apoptosis.  
 
Summarizing, our observations confirm that tryptophan deprivation in the 
microenvironment causes the inhibition of proliferation of primary human T-lymphocytes. 
We propose that cells lacking access to the essential amino acid tryptophan are not able to 
proliferate and expand in cell number but display increased apoptotic susceptibility. 
As a mechanism, neither the integrated stress response nor the autophagy pathway is 
initiated upon tryptophan starvation. From these findings we conclude that these two stress 
responsive pathways do not account for the reversible effect of tolerance induction through 
tryptophan depletion.  
However, the PI3K/mTOR pathway may play a role during the cellular adaption to 
tryptophan deprivation in primary human T-cells. However, the initiation of this pathway 
occurred only late after activation. Since the effect of tryptophan depletion on cell 
proliferation was detectable early after stimulation, our findings rather suggest that an 
increased apoptotic decline and cell cycle arrest may account for the inhibitory effect of 
tryptophan starvation on T-cell proliferation.  
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Further investigations on this project will include first the replenishment of tryptophan to 
cultures for showing if cellular proliferation is resumed and the inhibition of the PI3K/mTOR 
pathway could be compensated. Furthermore, the effect of kynurenines on primary human 
T-cells with regards to cellular proliferation, apoptotic response and inhibition of the 
PI3K/mTOR pathway will be investigated. Moreover, cell cycle studies have to be 
performed by monitoring cyclins (cyclin D), cyclin dependent kinases (CDK4) and cyclin 
dependent kinase inhibitors (p21, p27, p16INK4a) in order to identify the role of tryptophan 
depletion on cell cycle arrest, as shown by Munn et al. in 1999 [118], and apoptotic 
response. In addition, by inhibition of apoptosis i.e. by the caspase inhibitor Z-VAD, the 
effect of tryptophan withdrawal will be in depth analyzed with regards to proliferation and 
PI3K/mTOR pathway induction in primary human T-cells.  
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SUPPLEMENTAL 
  
ABSTRACT 
 
-A- 
ABSTRACT 
Indoleamine 2,3-dioxygenase (IDO) is responsible for the catalysis of tryptophan to 
tryptophan metabolites, which triggers a depletion of this essential amino acid and 
kynurenine accumulation in the microenvironment of T-cells. 
Tryptophan depletion through IDO was suggested as a molecular mechanism of IDO 
mediated immunosuppression and was also shown to activate the integrated stress 
response (ISR) via the GCN2 pathway in mice. This thesis aims to explore whether the 
effects of IDO on the GCN2 pathway are valid also in primary human T-cells, and whether 
the activation of the GCN2 pathway is associated with the impaired proliferative capacity in 
primary human T-cells upon sensing tryptophan deprivation.  
Our findings first confirmed that tryptophan deprivation accounts for the inhibition of 
proliferation in human T-lymphocytes. Although human primary T-cells are able to respond 
to an activation stimulus by highly expressed CD25 cell surface molecules, proliferation is 
inhibited. T-cell inhibition associated with tryptophan deprivation was accompanied by an 
increased susceptibility to apoptosis.  
Furthermore our data clearly indicated that, in contrast to the murine system, the integrated 
stress response was not induced upon tryptophan deprivation in primary human T-cells. 
Moreover, autophagy, an alternative stress related pathway, was not induced upon 
tryptophan withdrawal in the primary human system. Yet, the mammalian target of 
rapamycin (mTOR) pathway was inducible upon exposing primary human T-lymphocytes 
to enforced stress (tryptophan exhaustion, prolonged cell culture). 
In conclusion, in primary human T-cells, the initiation of the ISR and autophagy pathway 
apparently do not contribute to the cellular adaption to tryptophan deprivation. However, 
the mTOR pathway and increased apoptotic susceptibility may account for the T-cell 
inhibitory effects evoked by IDO activity.  
 KURZFASSUNG 
-B- 
KURZFASSUNG 
Indoleamine 2,3-dioxygenase (IDO) katalysiert die Umsetzung von Tryptophan zu 
Tryptophanmetaboliten. Dieser Prozess führt zur Erschöpfung dieser essentiellen 
Aminosäure in der direkten Umgebung der T-Zellen.  
In Mäusen wurde gezeigt, dass Tryptophan Abbau durch IDO den „Integrated Stress 
Response“ auslöst und somit als molekularer Mechanismus für die IDO vermittelte 
Immunsuppression fungiert.  
Ziel dieser Arbeit war, die Effekte von IDO im besonderen Bezug auf den GCN2 Signalweg 
zu erforschen und infolgedessen auch den Effekt von Tryptophan Erschöpfung infolge von 
Aktivierung des GCN2 Signalweges auf die Proliferation von humanen T-Zellen zu 
ergründen.  
Unsere Resultate haben bestätigt, dass die Ursache für eine inhibierte T-Zellproliferation 
im humanen System durch Tryptophanmangel hervorgerufen wird. Obwohl primäre 
humane T-Zellen durch hohe CD25 Zelloberflächen Expression im Stande sind, auf 
Aktivierung zu reagieren, sind sie in ihrer Proliferation gehemmt. Neben dieser Inhibierung 
durch Tryptophan Mangel wurde zusätzlich noch ein erhöhter Anteil an apoptotischen 
Zellen verzeichnet. 
Weiters haben unsere Daten deutlich gezeigt, dass der „Integrated Stress Response“, im 
Vergleich zum murinen System, in primären humanen T-Zellen nicht durch 
Tryptophanmangel hervorgerufen wird.  
Darüber hinaus wurde Autophagie, ein alternativer Signalweg der durch Stress induziert 
wird, nicht durch Tryptophanentzug induziert.  
Dahingegen wurde der mTOR Signalweg durch erhöhten Stress, wie zum Beispiel 
Tryptophanmangel und längere Kultivierung im Medium, in primären humanen 
T-Lymphocyten aktiviert 
Zusammenfassend haben die Ergebnisse dieses Projektes gezeigt, dass der „Integrated 
Stress Response“ und Autophagie Signalweg in primären humanen T-Zellen offenbar 
keine Rolle in Bezug auf die zelluläre Antwort, bedingt durch Tryptophanmangel, spielt. 
Nichtsdestotrotz könnten der mTOR Signalweg und erhöhte Apoptose, hervorgerufen 
durch IDO spezifischen Tryptophanentzug, eine wichtige Bedeutung hinsichtlich der 
T-Zellinhibierung darstellen.     
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